Children's Hormone Foundation

LIST OF PUBLICATIONS




  1. ​New MI, McNamara H, Kretchmer N: Accumulation of para‑amino‑hippurate by slices of kidney from rabbits of various ages.  Proc Soc Exp Biol Med 102:558‑560, 1959.
  2. New MI, Roberts TN, Bierman EL, Reader GG: The significance of blood lipid alterations in diabetes mellitus.  Diabetes 12:208‑212, 1963.
  3. New MI: Endocrine factors in growth.  Medical Science 15:52‑55, 1964.
  4. Bauer CH, New MI, Miller JM: Cerebrospinal fluid protein values of premature infants.  J Pediatr 6:1017‑1022, 1965.
  5. New MI, Miller B, Peterson RE: Aldosterone excretion in normal children and in children with adrenal hyperplasia.  J Clin Invest. 45:412‑428, 1966.
  6. New MI, Peterson RE: Disorders of aldosterone secretion in childhood.  Pediatr Clin North Am 13:43‑58, 1966.
  7. Greenberg AJ, Arboit JM, New MI, Worthen HG: Normotensive secondary hyperaldosteronism.  J Pediatr 69:719‑727, 1966.
  8. Bongiovanni AM, Eberlein WR, Goldman AS, New MI: Disorders of adrenal steroid biogenesis.  Rec Prog Horm Res 23:375‑449, 1967.
  9. New MI, Peterson RE: A new form of congenital adrenal hyperplasia.  J Clin Endocrinol Metab 27:300‑305, 1967.
  10. Grossman H, New MI: Precocious sexual development: Roentgenographic aspects.  Am J Roent Rad Ther Nucl Med 100:48‑62, 1967.
  11. Nadler AC, Sonenberg M, New MI, Free CA: Growth hormone activity in man with components of tryptic digests of bovine growth hormone.  Metabolism 16:830‑845, 1967.
  12. Curi JFJ, Vanucci RC, Grossman H, New MI: Elevated serum gonadotropins in Silver's syndrome.  Am J Dis Child 114:658‑661, 1967.
  13. New MI, Peterson RE: Aldosterone in childhood, In Advances in Pediatrics, SZ Levine (ed).  Year Book Medical Publishers, Chicago, 15:111‑136, 1968.
  14. New MI, Gross JM, Peterson RE: Double isotope dilution derivative technique for testosterone glucuronoside in urine.  Acta Endocrinologica 58:77‑97, 1968.
  15. New MI: Congenital adrenal hyperplasia.  Pediatric Clinics of North America 15:395‑407,1968.
  16. New MI, Seaman MP, Peterson RE: A method for the simultaneous determination of the  secretion rates of cortisol, 11‑desoxycortisol,corticosterone, 11‑desoxycorticosterone and aldosterone.  J Clin Endocrinol Metab 29:514‑522, 1969.
  17. Merkatz IR, New MI, Peterson RE, Seaman MP: Prenatal diagnosis of adrenogenital syndrome by amniocentesis.  J Pediatr 75:977‑982, 1969.
  18. Simpson JL, Allen Jr FH, New MI, German J: Absence of close linkage between the locus for Xg and the locus for anhidrotic ectodermal dysplasia.  Vox Sang 17:465‑467, 1969.
  19. New MI: Antenatal diagnosis of the adrenogenital syndrome (Letter to the Editor).  Lancet 1:83, 1970.
  20. New MI, Seaman MP: Secretion rates of cortisol and aldosterone precursors in various forms of congenital adrenal hyperplasia.  J Clin Endocrinol Metab 30:361‑371, 1970.
  21. New MI (with the technical assistance of Suvannakul L): Male pseudohermaphroditism due to 17a‑hydroxylase deficiency.  J Clin Invest 49:1930‑1941, 1970.
  22. New MI: Endocrinological disorders.  Bull Sloane Hosp Women 16:91‑99, 1970.
  23. New MI: Methods for the diagnosis of congenital adrenal hyperplasia.  In: FW Sunderman and FW Sunderman (eds), Laboratory Diagnosis of Endocrine Diseases.  Warren H Green Inc, St Louis, 1971, pp 517-524.
  24. Morillo‑Cucci G, New MI, Simpson JL, Allen Jr FH, German J: Abnormalities of human sex chromosomes III Duplication in the long arm of the Y chromosome (45,X/46,XYq+) in Y‑gonadal dysgenesis.  Ann Genet 14:113‑120, 1971.
  25. Levine LS, New MI: Preoperative detection of hidden testes, Am J Dis Child 121:176‑178, 1971.
  26. Bullock LP, New MI: Testosterone and cortisol concentration in spermatic, adrenal and systemic venous blood in adult male guinea pigs.  Endocrinology 88:523‑526, 1971.
  27. Simpson JL, New MI, Peterson RE, German J: Pseudovaginal perineoscrotal hypospadias (PPSH) in sibs. In: Proceedings of the Third Conference on Clinical Delineation of Birth Defects, VA McKusick (ed), In: Birth Defects: Original Article Series, vol 7, 1971, pp 140‑144.
  28. New MI, Parks GA, Landey S, Wiedemann E: Dwarfism associated with defective sulfation factor generation, Clin Res 19:378, 1971.
  29. Parks GA, Bermudez JA, Anast CS, Bongiovanni AM, New MI: Pubertal boy with the 3ß‑hydroxysteroid dehydrogenase defect.  J Clin Endocrinol Metab 33:269‑278, 1971.
  30. Giombetti R, Hagstrom JWC, Landey S. Young MC, New MI: Cushing's syndrome in infancy: a case complicated by monilial endocarditis.  Am J Dis Child 122:264‑266, 1971.
  31. Zachmann M, Vollmin JA, New MI, Curtius H‑CH, Prader A: Congenital adrenal hyperplasia due to deficiency of 11ß‑hydroxylation of 17a‑hydroxylated steroids.  J Clin Endocrinol Metab 33:501‑508, 1971.
  32. Sonenberg M, Yamasaki N, Kikutani M, Swislocki NI, Levine LS, New MI: Studies on active fragments of bovine growth hormone. In: A Pecile and EE Muller (eds), Growth and Growth Hormone, In: Excerpta Medica International Congress Series, No 244. 1972, pp 75-90.
  33. Parks, GA, New MI, Bongiovanni AM, Bermudez JA, Anast CS: Puberty in a male with 3ß‑ol‑dehydrogenase deficiency.  In: BB Saxena, CG Beling and HM Gandy (eds), Gonadotropins, John Wiley and Sons, NY, 1972, pp 535‑545.
  34. New MI, Schwartz E, Parks GA, Landey S, Wiedemann E: Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.  J Pediatr 80:620‑626, 1972.
  35. Levine LS, New MI, Pitt P, Peterson RE: Androgen production in boys with sexual precocity and congenital adrenal hyperplasia.  Metabolism 21:457‑464 1972.
  36. Shanies DD, Hirschhorn K, New MI: Metabolism of testosterone‑14C by cultured human cells.  J Clin Invest 51:1459‑1468, 1972.
  37. New MI: Adrenogenital syndrome.  In: A Dorfman (ed), Antenatal Diagnosis, A University of Chicago Press, Chicago, 1972, pp 153‑160.
  38. Opitz JM, Simpson JL, Sarto GE, Summitt RL, New MI, German J: Pseudovaginal perineoscrotal hypospadias.  Clin Genet 3:1‑26, 1971.
  39. New MI: Ambiguous genitalia.  Ortho Panel, 16:2‑5, 1973.
  40. Dahms WT, Gray G, Vrana M, New MI: Adrenocortical adenoma and ganglioneuroblastoma in a child: A case presenting as Cushing syndrome with virilization.  Am J Dis Child 125:608‑611, 1973.
  41. New MI, Siegal EJ, Peterson RE: Dexamethasone‑suppressible hyperaldosteronism.  J Clin Endocrinol Metab 37:93‑100, 1973.
  42. New MI, Levine LS: Congenital adrenal hyperplasia. In: H Harris and K Hirschhorn (eds), Advances in Human Genetics, vol 4, Plenum Press, New York 1973, pp 251‑326.
  43. Levine LS, Sonenberg M, New MI: Metabolic effects in children of a 37 amino acid fragment of bovine growth hormone.  J Clin Endocrinol Metab 37:607‑615, 1973.
  44. Saenger P, Shanies DD, New MI: Influence of medroxyprogesteroneacetate on testosterone metabolism by cultured human fibroblasts: A model for drug steroid interaction.  J Clin Endocrinol Metab 37:760‑764, 1973.
  45. McCrory WW, New MI, Yaffe SJ: Drugs and the Unborn Child, sponsored by The National Foundation‑March of Dimes, March, 1973.  Clin Pharmacol Therap 14(2), 1973.
  46. Sonenberg M, Levine LS, New MI, Saxena BB: Fragments of growth hormone, In: S Raiti (ed), Advances in Human Growth Hormone Research, National Pituitary Agency, DHEW Publication No (NIH) 74‑612, 1973, pp 467‑480.
  47. Parks GA, Dumars KW, Limbeck GA, Quinlivan WL, MI New: True agonadism: A misnomer.  J Pediatr 84:375‑380, 1974.
  48. Saenger P, Wiedemann E, Schwartz E, Korth‑Schutz S, Lewy JE, Riggio RR, Rubin AL, Stenzel KH, New MI: Somatomedin and growth after renal transplantation, Pediatr Res 8:163‑169, 1974.
  49. Korth‑Schutz S, Levine LS, Merkatz IR, New MI: An unusual case of Cushing's syndrome, Hilus cell tumor and polycystic ovaries.  J Clin Endocrinol Metab 38:794‑800, 1974.
  50. Bennett SP, Levine LS, Siegal EJ, Lewy JE, Susin M, Peterson RE, New MI: Juvenile hypertension caused by overproduction of renin with in a renal segment.  J Pediatr 84:689‑695, 1974.
  51. Saenger P, Levine LS, Wiedemann E, Schwartz E, New MI: Growth with absent growth hormone by radioimmunoassay (Letter to the Editor).  J Pediatr 85:137‑138, 1974.
  52. Parks GA, Korth‑Schutz S, Penny R, Hilding RF, Dumars KW, Frasier SD, MI New: Variation in pituitary‑gonadal function in adolescent male homosexuals and heterosexuals.  J Clin Endocrinol Metab 39:796‑801, 1974.
  53. Canale VC, Steinherz P, New MI, Erlandson M: Endocrine function in thalassemia major.  Ann NY Acad Sci 232:333‑345, 1974.
  54. New MI, Levine LS: Congenital adrenal hyperplasia.  Ped Annals 3:27‑53, 1974.
  55. Rifkind AB, Bennett S, Forster ES, New MI: Components of the heme biosynthetic pathway and mixed function oxidase activity in human fetal tissues.  Biochem Pharmacol 24:839‑846, 1975.
  56. Lewy JE, New MI: Growth in children with renal failure.  Am J Med 58:65‑68, 1975.
  57. Doberne Y, Levine LS, New MI: Elevated urinary testosterone and androstenediol in precocious adrenarche.  Pediatr Res 9:794‑797, 1975.
  58. Saenger P, Rifkind AB, New MI: Changes in drug metabolism in children with thyroid disorders.  J Clin Endocrinol Metab 42:155‑159, 1976.
  59. Saenger P, Schwartz E, Wiedemann E, Levine LS, Tsai M, New MI: The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome.  Acta Endocrinologica 81:9‑18, 1976.
  60. Levine LS, Lewy JE, New MI: Hypertension in high school students: Evaluation in New York City.  NYS J Med 76:40‑44, 1976.
  61. Korth‑Schutz S, Levine LS, New MI (with the technical assistance of DM Chow), Serum androgens in normal prepubertal and pubertal children and in children with precocious adrenarche.  J Clin Endocrinol Metab 42:117‑124, 1976.
  62. Doberne Y, New MI: Urinary androstenediol and testosterone in adults.  J Clin Endocrinol Metab 42:152‑154, 1976.
  63. Saenger P, Levine LS, Wiedemann E, Schwartz E, New MI: Somatomedin in cerebral gigantism (Letter to the Editor).  J Pediatr 88:155‑156, 1976.
  64. New MI, Baum CJ, Levine LS: Nomograms relating aldosterone excretion to urinary sodium and potassium in the pediatric population: Their application to the study of childhood hypertension.  Am J Cardiol 37:658‑666, 1976.
  65. Korth‑Schutz S, Levine LS, New MI (with the technical assistance of DM Chow), Evidence for the adrenal source of androgens in precocious adrenarche.  Acta Endocrinologica 82:342‑352, 1976.
  66. Korth‑Schutz S, Levine LS, New MI (with the technical assistance of DM Chow): Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion.  J Clin Endocrinol Metab 42:1005‑1013,1976.
  67. Wachtel SS, Koo GC, Breg WR, Thaler HT, Dillard GM, Rosenthal IM, Dosik H, Gerald PS, Saenger P, New MI, Lieber E, Miller OJ: Serologic detection of an Y‑linked gene in XX males and XX true hermaphrodites.  New Engl J Med 295:750‑754, 1976.
  68. Saenger P, Levine LS, Wachtel SS, Korth‑Schutz S. Doberne Y, Koo GC, Lavengood Jr RW, German III JL, New MI: Presence of H‑Y antigen and testis in 46,XX true hermaphroditism, evidence for Y‑chromosomal function, J Clin Endocrinol Metab 43:1234‑1239, 1976.
  69. New MI, Peterson RE, Saenger P, Levine LS: Evidence for an unidentified ACTH‑induced steroid hormone causing hypertension.  J Clin Endocrinol Metab 43:1283‑1293, 1976.
  70. New MI: Prenatal diagnosis of congenital adrenal hyperplasia, In: MI New, RH Fiser Jr (eds), Diabetes and Other Endocrine Disorders During Pregnancy and in the Newborn, In: Progress in Clinical and Biological Research, vol 10, Alan R Liss, New York, 1976, pp 205‑219.
  71.   Rifkind AB, Canale V, New MI: Antipyrine clearance in homozygous ß‑thalassemia.  Clin Pharm Therap 20:476‑483, 1976.
  72. Korth‑Schutz S, Levine LS, Roth JA, Saenger P, New MI: Virilizing adrenal tumor in a child suppressed with dexamethasone for three years: Effect of o,p'‑DDD on serum and urinary androgens.  J Clin Endocrinol Metab 44:433‑439, 1977.
  73. MI: Present status of prenatal diagnosis of congenital adrenal hyperplasia, In: PA Lee, LP Plotnick, AA Kowarski and CJ Migeon (eds), Congenital Adrenal Hyperplasia, University Park Press, Baltimore, 1977, pp 511‑526.
  74. Levine LS, Korth‑Schutz S, Saenger P, Sweeney III WJ, Beling CG, New MI: Disordered puberty in treated congenital adrenal hyperplasia.  In: PA Lee, LP Plotnick, AA Kowarski and CJ Migeon (eds), Congenital Adrenal Hyperplasia, University Park Press, Baltimore, 1977, pp 361‑378.
  75. Ulick S, Ramirez LC, New MI: An abnormality in steroid reductive metabolism in a hypertensive syndrome.  J Clin Endocrinol Metab 44:799‑802, 1977.
  76. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S: Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.  J Clin Endocrinol Metab 44:924‑933, 1977.
  77. New MI, Levine LS: Mineralocorticoid hypertension in childhood.  Mayo Clin Proc 52:323‑328, 1977.
  78. Koo GC, Wachtel SS, Saenger P, New MI, Dosik H, Amarose AP, Dorus E, Ventruto V: H‑Y antigen: Expression in human subjects with the testicular feminization syndrome.  Science 196:655‑656, 1977.
  79. New MI, Levine LS:  An unidentified ACTH‑stimulable adrenal steroid in childhood hypertension.  In: MI New and LS Levine (eds), Juvenile Hypertension, Raven Press, New York, 1977, pp 143‑163.
  80. New MI: Prenatal diagnosis of congenital adrenal hyperplasia.  In: HL Vallet and IH Porter (eds), Genetic Mechanisms of Sexual Development, Academic Press, New York, 1979, pp 197‑220.
  81. Saenger P, Goldman AS, Levine LS, Korth‑Schutz S, Muecke EC, Katsumata M, Doberne Y, New MI: Prepubertal diagnosis of steroid 5a‑reductase deficiency.  J Clin Endocrinol Metab 46:627‑634, 1978.
  82. Rosler A, Levine LS, Schneider B, Novogroder M, New MI: The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.  J Clin Endocrinol Metab 45:500‑512, 1977.
  83. Saenger P, New MI: Inhibitory action of dehydroepiandrosterone (DHEA) in fibroblast growth.  Experientia 33:966‑967, 1977.
  84. Saenger P, Levine LS, Wiedemann E, Schwartz E, Korth‑Schutz S, Pareira J, Heinig B and New MI: Somatomedin and growth hormone in psychosocial dwarfism.  Padiatrie und Padologie (suppl 5):1‑12, 1977.
  85. New MI, Virdis R, Virdis P: Ipertensione ormonale dell'infanzia, Problemi Attuali in Pediatria, 13‑26, 1977.
  86. McVie R, Levine LS, New MI: The biologic significance of the aldosterone concentration in saliva.  Pediatr Res 13:755‑759, 1979.
  87. Korth‑Schutz S, Virdis R, Saenger P, Chow DM, Levine LS, New MI: Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia.  J Clin Endocrinol Metab 46:452‑458, 1978.
  88. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI: Microfilter paper method for 17a‑hydroxyprogesterone radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia.  J Clin Endocrinol Metab 45:1003‑1008, 1977.
  89. New MI, Rauh W: Childhood obesity and hypertension.  In: E Cacciari, Z Laron, and S Raiti (eds), Obesity in Childhood, Proceedings of the Serono Symposia, vol 17,  Academic Press, London, 1978, pp 87‑90.
  90. Virdis R, Saenger P, Senior B, New MI: Endocrine studies in a pubertal male pseudohermaphrodite with 17‑ketosteroid reductase deficiency.  Acta Endocrinologica 87:212‑224, 1978.
  91. New MI et al: Report of the Hypertension Task Force: Current Research and Recommendations from the Task Force Subgroups on Pediatrics and Genetics, Volume 6, DHEW Publication No (NIH) 79‑1628, 1979.
  92. New MI: H‑Y antigen and abnormal sex determination. In: OP Ghai (ed), New Developments in Pediatric Research, Proceedings of the XV International Congress of Pediatrics, Interprint, 1977, pp 1119‑1120.
  93. New MI, Levine LS: Pathogenesis and endocrinological aspects of hypertension, In: OP Ghai (ed), New Developments in Pediatric Research, Proceedings of the XV International Congress of Pediatrics, Interprint, 1977, pp 61‑669.
  94. New MI, Levine LS: Adrenocortical hypertension.  Pediatr Clin North Am 25:67‑81, 1978.
  95. New MI: Ambiguous sex in the newborn: Genital anomalies.  In: Perspectives on Sex and Gender‑A Multidisciplinary Conference, Institute for Urban and Minority Education, New York, pp 18‑20, 1979.
  96. New MI, Levine LS: An unidentified ACTH stimulable adrenal steroid in childhood hypertension.  In: G Chiumello and Z Laron (eds), Recent Progress in Pediatric Endocrinology, Proceedings of the Serono Symposia, vol 12,  Academic Press, New York, 1977. pp 249‑267.
  97. Oberfield SE, Levine LS, Carey RM, Bejar R, New MI: Pseudohypoaldosteronism: Multiple target organ unresponsiveness to mineralocorticoid hormones.  J Clin Endocrinol Metab 48:228‑234, 1979.
  98. Ferraris J, Saenger P, Levine LS, New MI, Pang S, Saxena BB, Lewy JE: Delayed puberty in males with chronic renal failure.  Kidney Int 18:344‑350, 1980.
  99. New MI, Rauh W: Childhood obesity and hypertension.  In: PJ Collipp (ed), Childhood Obesity, 2nd edition, PSG Publishing Co, Mass, 1980, pp 57‑61.
  100. Rauh W, Levine LS, Gottesdiener K, New MI, Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.  Klin Wochenschr, 56(suppl I):161‑167, 1978.
  101. Levine LS, Novogroder M, Saxena B, Saenger P, Saito I, New MI: Primary intracranial HCG‑producing germinoma in a boy with congenital adrenal hyperplasia.  Acta Endocrinol 88:122‑131, 1978.
  102. Levine LS, Zachmann M, New MI, Prader A, Pollack MS, O'Neill GJ, Yang SY, Oberfield SE, Dupont B: Genetic mapping of the 21‑hydroxylase‑deficiency gene within the HLA linkage group.  N Engl J Med 299:911‑915, 1978.
  103. New MI: Guidelines for screening and treating hypertensive children.  Modern Med 46:36‑45, 1978.
  104. Pang S, Levine LS, Chow D, Sagiani F, Saenger P, New MI: Dihydrotestosterone and its relationship to testosterone in infancy and childhood.  J Clin Endocrinol Metab 48:821‑826, 1979.
  105. Pang S, Levine LS, Chow DM, Faiman C, New MI: Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21‑hydroxylase deficiency.  Clin Endocrinol 11:575‑584, 1979.
  106. Rauh W, Gottesdiener K, Chow D, Forster E, Saenger P, Levine LS, New MI: Aldosterone response to prolonged ACTH infusion in juvenile hypertension. Pediatr Res 14:1035‑39,1980.
  107. Voccia E, Saenger P, Peterson RE, Rauh W, Gottesdiener K, Levine LS, New MI: 6-Beta- hydroxycortisol excretion in hypercortisolemic states.  J Clin Endocrinol Metab 48:467‑71,1979.
  108. Lorenzen F, Pang S, New MI, Dupont B, Pollack M, Chow DM, Levine LS: Hormonal phenotype and HLA‑genotype in families of patients with congenital adrenal hyperplasia (21‑hydroxylase deficiency).  Pediatr Res 13:1356‑1360, 1979.
  109. Rauh W, Levine LS, Gottesdiener K, Chow D, Oberfield SE, Gunczler P, Pareira P, New MI: Adrenocortical function, electrolyte metabolism, and blood pressure during prolonged adrenocorticotropin infusion in juvenile hypertension.  J Clin Endocrinol Metab 49:52‑7, 1979.
  110. New MI, Lorenzen F, Pang S, Gunczler P, Dupont B, Levine LS: "Acquired" adrenal hyperplasia with 21‑hydroxylase deficiency is not the same genetic disorder as congenital adrenal hyperplasia.  J Clin Endocrinol Metab 48:356‑359, 1979.
  111. Loggie JMH, New MI, Robson AM: Hypertension in the pediatric patient: A reappraisal.  J Pediatr 94:685‑699, 1979.
  112. Loggie JMH, Londe S, New MI: Pediatric hypertension: Add HBP to your list of childhood ills.  Patient Care 12:16‑24, 1978.
  113. New MI, Gurpide E, Levine LS, Segal SJ, Soyka LF, VanWyk JJ, Yaffe SJ: Report of the Conference on Estrogen Treatment of the Young.  Pediatrics 62 part 2 (suppl):1087‑1217, 1978.
  114. Saenger P, Levine LS, Pang S, New MI: Sexual ambiguity at birth. In: SJ Kogan and ESE Hafez (eds), Diagnosis in Andrology, Vol 4, Martinus Nijhoff Publishers, Boston, 1980, pp 31‑52.
  115. Yang SY, Levine LS, Zachmann M, New MI, Prader A, Oberfield SE, O'Neill GJ, Pollack MS and Dupont B: Mapping of the 21‑hydroxylase deficiency gene within the HLA linkage group.  Transplant Proc 10:753‑755, 1978.
  116. Brautbar C, Rosler A, Landau H, Cohen I, Nelken D, Cohen T, Levine C, Sack J, Benderli A, Moses A, Lieberman E, Dupont B, Levine LS and New MI: No linkage between HLA and congenital adrenal hyperplasia due to 11‑ß‑hydroxylase deficiency (Letter to the Editor). N Engl J Med 300:205‑206, 1979.
  117. Oberfield SE, Case DB, Levine LS, Rapaport R, Rauh W, New MI: Use of the oral angiotensin I‑converting enzyme inhibitor (Captopril) in childhood malignant hypertension.  J Pediatr 95:641‑644, 1979.
  118. Pang S, Shine S, Levine LS and New MI: Practical advances in cortisol and dehydroepiandrosterone sulfate radioimmunoassay using microfilter paper method.  J Lab Clin Med 95:515‑524, 1980.
  119. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol.  J Clin Endocrinol Metab 49:757‑764, 1979.
  120. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgartner MW: Depressed serum somatomedin activity in ß‑thalassemia.  J Pediatr 96:214‑218, 1980.
  121. Pollack MS, Levine LS, Pang S, Owen RP, Nitowsky HM, Maurer D, New MI, Duchon M, Merkatz IR, Sachs G, Dupont B: Prenatal diagnosis of congenital adrenal hyperplasia (21‑hydroxylase deficiency) by HLA typing. Lancet 1:1107‑8, 1979.
  122. Pollack MS, Maurer D, Levine LS, New MI, Pang S, Duchon MA, Owens RP, Merkatz IR, Nitowsky HM, Sachs G, Dupont B: HLA typing of amniotic cells: The prenatal diagnosis of congenital adrenal hyperplasia (21‑OH‑deficiency type).  Transplant Proc XI:1726‑1728, 1979.
  123. Newman CB, Levine LS, New MI: Endocrine function in children with intrasellar and suprasellar neoplasms before and after therapy.  Am J Dis Child 135:259‑262, 1981.
  124. New MI, Levine LS: Endocrine diseases. In: E Wasserman and DS Gromish (eds), Survey of Clinical Pediatrics, 7th edition,  McGraw‑Hill Book Company, New York, 1981, pp 427‑454.
  125. Oberfield SE, Levine LS, Wellner D, Novogroder M, Laino P, New MI: Ascorbic acid treatment in nephropathic cystinosis in identical twins.  Dev Pharmacol Therap 2:80‑90, 1981.
  126. Levine LS, New MI: Endocrine aspects of hypertension.  In: CGD Brook (ed), Clinical Paediatric Endocrinology, Blackwell Scientific Publications, Oxford, 1981, pp 479‑491.
  127. O'Neill GJ, Pollack MS, Yang SY, Levine LS, New MI, Dupont B: Gene frequencies and genetic linkage disequilibrium for the HLA linked genes Bf, C2, C4S, C4F, 21‑hydroxylase deficiency and glyoxalase I.  Trans Proc 11:1713‑1718, 1979.
  128. Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter JD: Radioreceptor assay of plasma mineralocorticoid activity: role of aldosterone, cortisol and deoxycorticosterone in various mineralocorticoid‑excess states.  Circ Res 46(suppl I):94‑100, 1980.
  129. Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia.  Invest Urol 17:169‑175, 1979.
  130. Lorenzen F, Pang S, New MI, Pollack MS, Oberfield SE, Dupont B, Chow D, Schneider B, Levine LS: Studies of the C‑21 and C‑19 steroids and HLA genotyping in siblings and parents of patients with congenital adrenal hyperplasia due to 21‑hydroxylase deficiency.  J Clin Endocrinol Metab 50:572‑577, 1980.
  131. Levine LS, Rauh W, Gottesdiener K, Chow D, Gunczler P, Rapaport R, Pang S, Schneider B, New MI: New studies of the 11ß‑hydroxylase and 18‑hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.  J Clin Endocrinol Metab 50:258‑263, 1980.
  132. Pang S, Levine LS, Cederqvist LL, Fuentes M, Riccardi VM, Holcombe JH, Nitowsky HM, Sachs G, Anderson CE, Duchon MA, Owens R, Merkatz I, New MI: Amniotic fluid concentrations of _5 and _4 steroids in fetuses with congenital adrenal hyperplasia due to 21‑hydroxylase deficiency and in anencephalic fetuses, J Clin Endocrinol Metab 51:223‑229,1980.
  133. Pang S, Levine LS, Lorenzen F, Chow D, Pollack MS, Dupont B, Genel M, New MI: Hormonal studies in obligate heterozygotes and siblings of patients with 11ß‑hydroxylase deficiency congenital adrenal hyperplasia.  J Clin Endocrinol Metab 50:586‑589, 1980.
  134. Laron Z, Pollack MS, Zamir R, Roitman A, Dickerman Z, Levine LS, Lorenzen F, O'Neill GJ, Pang S, New MI, Dupont B: Late onset 21‑hydroxylase deficiency and HLA in the Ashkenazi population: A new allele at the 21‑hydroxylase locus.  Human Immunol 1:55‑66, 1980.
  135. Pollack MS, Levine LS, Zachmann M, Prader A, New MI, Oberfield SE, Dupont B: Possible genetic linkage disequilibrium between HLA and the 21‑hydroxylase deficiency gene (congenital adrenal hyperplasia).  Trans Proc XI:1315‑1316, 1979.
  136. Levine LS, New MI, Pollack MS, Dupont B: Prenatal diagnosis of congenital adrenal hyperplasia (Letter to the Editor).  Lancet 2:637, 1979.
  137. New MI, Oberfield SE, Levine LS, Dupont B, Pollack MS, Gill Jr JR, Bartter FC: Autosomal dominant transmission and absence of HLA linkage in dexamethasone‑suppressible hyperaldosteronism (Letter to the Editor).  Lancet 1:550‑551, 1980.
  138. Levine LS, Pang S, Dupont S, Pollack MS, Lorenzen L, New MI: Detection of heterozygote of 21‑hydroxylase deficiency (Letter to the Editor), Lancet 1:603‑604, 1980.
  139. Sonino N, Levine LS, Vecsei P, New MI: Parallelism of 11ß‑ and 18‑hydroxylation demonstrated by urinary free hormones in man.  J Clin Endocrinol Metab 51:557‑560, 1980.
  140. Sonino N, Chow D, Levine LS, New MI: Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children.  Clin Endocrinol (Oxf) 14:31‑39, 1981.
  141. New MI, Levine LS: Low‑renin hypertension with hyperaldosteronism in childhood, Prog Biochem Pharmacol 17:54‑57, 1980.
  142. New MI, Dupont B, Levine LS: HLA and adrenal disease.  In: NR Farid (ed), HLA in Endocrine and Metabolic Disorders, Academic Press, New York, 1981, pp 177‑208.
  143. Saenger P, Levine LS, New MI: Male pseudohermaphroditism due to abnormal testosterone biosynthesis and metabolism, In: SJ Kogan and ESE Hafez (eds), Clinics in Andrology, Vol 7.  In: Pediatric Andrology, Martinus Nijhoff Publishers, Boston, 1981, pp 87‑97.
  144. New MI, Levine LS: Inborn errors of steroid biosynthesis.  In: HLJ Makin (ed), Biochemistry of Steroid Hormones, Second Edition, Blackwell Scientific Publishers, Oxford, 1984, pp 595‑632.
  145. New MI, Levine LS: Congenital adrenal hyperplasia.  In: AJ Moss (ed), Pediatrics Update: Reviews for Physicians, 1981 Edition, Elsevier North Holland, New York, 1981, pp 223‑235.
  146. New MI, Levine LS: Adrenal hyperplasia in intersex states.  In: N Josso (ed),  Intersex Child,  In: Z Laron (ed), Pediatric and Adolescent Endocrinology, S Karger, Basel, 1981, 8:51‑64.
  147. New MI, Levine LS: Female pseudohermaphroditism.  In: JJ Sciarra, L Speroff, and JL Simpson (eds), Gynecology and Obstetrics, vol 5, Harper and Row, Hagerstown, 1981, pp 1‑7.
  148. Sonino N, Levine LS, New MI: Mineralocorticoid and metabolic response to metyrapone in normotensive children and children with dexamethasone‑suppressible and primary hyperaldosteronism.  Acta Endocrinol 98:87‑94, 1981.
  149. New MI, Levine LS: Hypertension of childhood with suppressed renin, Endocrine Reviews 1:421‑430, 1980.
  150. New MI, Levine LS (guest editors): Endocrine disorders in children.  Pediatr Ann 9:131‑173, 1980.
  151. New MI, Levine LS (guest editors): Hormonal conditions.  Pediatr Ann 9:359‑405, 1980.
  152. Oberfield SE, Levine LS, Rauh W, Pang S, Gottesdiener K,  New MI: Androgens in childhood hypertension.  In: E Cacciari and A Prader (eds), Pathophysiology of Puberty: Proceedings of the Serono Symposia, Vol 36, Academic Press, London, 1980, pp 157‑162.
  153. Rauh W, Levine LS, New MI: The role of dietary salt in juvenile hypertension, In: G Giovannelli, MI New and S Gorini (eds), Hypertension in Children and Adolescents,  Raven Press, New York, 1981, pp 35‑44.
  154. New MI: Investigation of new forms of hypertension in childhood.  In: G Giovannelli, MI New and S Gorini (eds), Hypertension in Children and Adolescents, Raven Press, New York, 1981, pp 157‑160.
  155. New MI, Levine LS: Hypertension in childhood and adolescence.  Cardiovas Rev Rep, 3:115‑122, 1982.
  156. Levine LS, Dupont B, Lorenzen B, Pang S, Pollack MS, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI: Cryptic 21‑hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.  J Clin Endocrinol Metab 51:1316‑1324, 1980.
  157. Dupont B, Pollack MS, Levine LS, O'Neill GJ, Hawkins BR, New MI: Congenital adrenal hyperplasia: Joint report from the 8th International Histocompatibility Workshop.  In: PI Terasaki (ed), Histocompatibility Testing 1980, UCLA Tissue Typing Laboratory, Los Angeles, 1980, pp 693‑706.
  158. Curtis JA, Monaghan HP, New MI, Bailey JD: Selective hypoaldosteronism in infancy.  Am J Dis Child 137:633‑636, 1983.
  159. Rifkind AB, Saenger P, Levine LS, Pareira J, New MI: Effects of growth hormone on antipyrine kinetics in children.  Clin Pharmacol Therap 30:l27‑l32, 1981.
  160. New MI, Levine LS: The infant with ambiguous genitalia.  In: Syllabus 32nd Ann Postgraduate Assembly of the Endocrine Society, 1980, pp 470.
  161. Kuhnle U, Chow D, Rapaport R, Pang S, Levine LS, New MI: The 21‑hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.  J Clin Endocrinol Metab 52:534‑544, 1981.
  162. Mininberg DT, Levine LS, New MI: Current concepts in congenital adrenal hyperplasia.  In: Advances in the Study of Birth Defects, Chap 11, In: TVN Persaud (ed), Genetic Disorders, Syndromology and Prenatal Diagnosis, Vol 5,MTP Press, Ltd, Lancaster, 1982, pp 181‑196.
  163. Teitelman G, Joh TH, Park D, Brodsky M, New MI, Reis DJ: Expression of the adrenergic phenotype in cultured fetal adrenal medullary cells: role of intrinsic and extrinsic factors.  Develop Biology 89:450‑459, 1982.
  164. New MI, Dupont B, Pang S, Pollack MS, Levine LS: An update of congenital adrenal hyperplasia.  Rec Prog Horm Res 37:105‑181, 1981.
  165. New MI, Levine LS, Pang S: Adrenal androgens and growth.  In: M Ritzen, A Aperia, K Hall, A Larsson, A Zetterberg, and R Zetterstrom (eds), The Biology of Normal Human Growth, Raven Press, New York, 1981, pp 285‑295.
  166. Lee SM, Lightner E, Witte M, Oberfield SE, Levine LS, New MI: Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis, Acta Endocrinol 99:251‑255, 1982.
  167. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack MS, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI: Genetic and hormonal characterization of cryptic 21‑hydroxylase deficiency.  J Clin Endocrinol Metab 53:1193‑1198, 1981.
  168. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS: Genotyping steroid 21‑hydroxylase deficiency: hormonal reference data.  J Clin Endocrinol Metab 57:320‑326, 1983.
  169. New MI, Grumbach K, Levine LS: Congenital adrenal hyperplasia, In: AEH Emery and DL Rimoin (eds), Principles and Practice of Medical Genetics, Churchill Livingstone, Inc, New York, 1983, pp 1202‑1226.
  170. Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Baxter JD: Role of steroids in various states of mineralocorticoid‑excess hypertension: Analysis by mineralocorticoid receptor assay.  In: G Giovannelli, MI New, and S Gorini (eds), Hypertension in Children and Adolescents, Raven Press, New York, 1981, pp 165‑175.
  171. Pollack MS, Levine LS, O'Neill GJ, Pang S, Lorenzen F, Kohn B, Rondanini GF, Chiumello G, New MI, Dupont B: HLA linkage and B14,DR1,BfS haplotype association with the genes for late onset and cryptic 21‑hydroxylase deficiency.  Am J Hum Genet 33:540‑550, 1981.
  172. Rapaport R, Levine LS, Petrovic M, Wilson T, Draznin M, Bejar RL, Johanson A, New MI: The renin‑aldosterone system in cystic fibrosis, J Pediatrics 98:768‑771, 1981.
  173. New MI, Dupont B, Pollack MS, Levine LS: The biochemical basis for genotyping 21‑hydroxylase deficiency.  Human Genetics 58:123‑127, 1981.
  174. Pollack MS, New MI, O'Neill GJ, Levine LS, Callaway C, Pang S, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni E, Dupont B: HLA genotypes and HLA‑linked genetic markers in Italian patients with classical 21‑hydroxylase deficiency.  Human Genetics 58:331‑337, 1981.
  175. New MI: The role of steroid hormones in the development of low‑renin hypertension of childhood. In: JMH Loggie, MJ Horan, AB Gruskin, AR Hohn, JB Dunbar and RJ Havlik (eds), NHLBI Workshop on Juvenile Hypertension: Proceedings from a Symposium, Bethesda, Maryland, May 26 ‑ 27, 1983, Biomedical Information Corp, New York, 1984, pp 283‑304.
  176. Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee SM, Lightner E, Witte M, New MI: Adrenal glomerulosa function in patients with dexamethasone‑suppressible hyperaldosteronism.  J Clin Endocrinol Metab 53:158‑164, 1981.
  177. Kuhnle U, Rosler A, Pareira JA, Gunczler P, Levine LS, New MI: The effects of long‑term normalization of sodium balance on linear growth in disorders with aldosterone deficiency.  Acta Endocrinol 102:577‑582, 1983.
  178. New MI: Precocious puberty, In: DT Krieger and CW Bardin (eds), Current Therapy in Endocrinology 1983‑1984, BC Decker, Philadelphia, 1983, pp 7‑11.
  179. Wachtel SS, New MI: Studies on H‑Y antigen: The genetic basis of abnormal gonadal differentiation.  In: Clinics in Andrology, Vol 7.  In: SJ Kogan and ESE Hafez (eds), Pediatric Andrology, Martinus Nijhoff Publishers, Boston, 1981, pp 59‑69.
  180. Pang S, Murphey M, Levine LS, Spence DA, Leon A, LaFranchi S, Surve AS, New MI: A pilot newborn screening for congenital adrenal hyperplasia in Alaska.  J Clin Endocrinol Metab 55:413‑420, 1982.
  181. New MI, Levine LS (guest editors): Endocrine disorders.  Ped Annals 10:323‑375, 1981.
  182. New MI, Levine LS: New developments in congenital adrenal hyperplasia.  Ped Annals 10:346‑355, 1981.
  183. New MI, Levine LS: Hypertension and the adrenal cortex.  In: SA Kaplan (ed), Clinical Pediatric and Adolescent Endocrinology, WB Saunders Co, Philadelphia, 1982, pp 187‑198.
  184. Levy DJ, Levine LS, New MI: Male pseudohermaphroditism.  Ped Review 3:273‑283, 1982.
  185. New MI, Dupont B, Grumbach K, Levine LS: Congenital adrenal hyperplasia and related conditions.  In: JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, and MS Brown (eds), The Metabolic Basis of Inherited Disease, 5th edition, McGraw‑Hill Book Company, New York, 1982, pp 973‑1000.
  186. New MI, Levine LS: Congenital adrenal hyperplasia.  Clin Biochem 14:258‑272, 1981.
  187. Saenger P, Levine LS, Irvine WJ, Gottesdiener K, Rauh W, Sonino N, Chow D, New MI: Progressive adrenal failure in polyglandular auto immune disease.  J Clin Endocrinol Metab 54:863‑868, 1982.
  188. Mininberg DT, Levine LS, New MI: Congenital adrenal hyperplasia.  Pathology Annual 17:179‑195, 1982.
  189. New MI, Dupont B, Pang S, Pollack MS, Levine LS: Metabolic errors of adrenal steroidogenesis, In: Fetal Endocrinology and Metabolism.  In: L Martini and VHT James (eds), Current Topics in Experimental Endocrinology, Vol 5, Academic Press, New York, 1983, pp 309‑358.
  190. New MI, Stoner E, Pang S, Levine LS: Genetic steroidogenic defects causing abnormal pubertal changes.  In: S Venturoli, C Flamigni, JR Givens (eds), Adolescence in Females, Proceedings of the Eighth Annual Symposium on Gynecologic Endocrinology, October 24‑26, 1983, University of Bologna, Bologna, Italy, Year Book Medical Publishers, Chicago, 1985, pp 341‑372.
  191. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS: Long term endocrine sequelae following treatment of medulloblastoma: a prospective study of growth and thyroid function.  J Pediatrics, 108:219‑223, 1986.
  192. Levine LS, New MI: Neoplasms associated with congenital adrenal hyperplasia (Letter to the Editor).  J Pediatrics 100:506‑507, 1982.
  193. New MI, Oberfield SE, Carey RM, Greig F, Ulick S, Levine LS: A genetic defect in cortisol metabolism as the basis for the syndrome of apparent mineralocorticoid excess.  In: F Mantero, EG Biglieri and CRW Edwards (eds), Endocrinology of Hypertension, Serono Symposia No 50, Academic Press, New York, 1982, pp 85‑101.
  194. New MI, Dupont B, Lorenzen F, Pang S, Pollack MS, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, Levine LS: Recognition of allelic variants of 21‑hydroxylase deficiency by HLA genotyping, hormonal and clinical evaluation, In: G Chiumello and M Sperling (eds), Recent Progress in Pediatric Endocrinology, Serono Series, Raven Press, New York, 1983, pp 183‑219.
  195. Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI: Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.  J Clin Endocrinol Metab 56:332‑339, 1983.
  196. Oberfield SE, Levine LS, New MI: Adrenal disorders: causes and therapy for children and adolescents.  Consultant 22:328‑343, 1982.
  197. Meyer‑Bahlburg HFL, Ehrhardt AA, Bell JJ, Cohen SF, Healey JM, Feldman JF, Morishima A, Baker SW, New MI:  Idiopathic precocious puberty in girls:  psychosexual development.  J Youth Adol 14:339‑353, 1985.
  198. O'Neill GJ, Dupont B, Pollack MS, Levine LS, New MI: Complement C4 allotypes in congenital adrenal hyperplasia due to 21‑hydroxylase deficiency: further evidence for different allelic variants at the 21‑hydroxylase locus.  Clin Immunol Immunopathol 23:312‑322, 1982.
  199. New MI, Oberfield SE, Levine LS: Hypertension in children. In: J Genest, O Kuchel, P Hamet, M Cantin (eds), Hypertension: Pathophysiology and Treatment (2nd edition), McGraw‑Hill Book Co, New York, 1983 pp 853‑889.
  200. New MI, Levine LS: Steroid 21‑hydroxylase deficiency.  In: MI New and LS Levine (eds), Adrenal Diseases in Childhood,  In: Z Laron (ed), Pediatric and Adolescent Endocrinology, Vol 13, S Karger AG, Basel, pp 1984,1‑46.
  201. Oberfield SE, Rapaport R, Levine LS, New MI: Long‑term treatment of childhood hypertension with captopril.  Ped Annals 11:614‑621, 1982.
  202. Oberfield SE, Levine LS, New MI: Childhood hypertension due to adrenocortical disorders.  Ped Annals 11:623‑628, 1982.
  203. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner A, Rondanini GF, Dupont B, New MI: Late‑onset steroid 21‑hydroxylase deficiency: A variant of classical congenital adrenal hyperplasia.  J Clin Endocrinol Metab 55:817‑827, 1982.
  204. New MI: Erkrankungen der nebennierenrinde: 11ß‑ und 21‑hydroxylase mangel [Adrenocortical Dysfunction: 21‑ and 11ß‑hydroxylase deficiencies].  In: D Gupta (ed),  Endokrinologie der Kindheit und Adoleszenz, Georg, Thieme, Verlag, New York, 1986, pp 182‑228.
  205. New MI, Levine LS, Oberfield SE: Low renin hypertension in childhood, In: F Lifshitz (ed), Pediatric Endocrinology, A Clinical Guide, Marcel Dekker, New York, 1985, pp 591‑614.
  206. New MI, Pang S, Levine LS: An update of congenital adrenal hyperplasia.  In: F Lifshitz (ed), Pediatric Endocrinology, A Clinical Guide, Marcel Dekker, New York, 1985, pp 203‑235.
  207. Oberfield SE, Levine LS, Firpo A, Lawrence D, Stoner E, Levy DJ, Sen S, New MI: Primary hyperaldosteronism in childhood due to unilateral macronodular hyperplasia.  Hypertension, 6:75‑84, 1984.
  208. Loche S, Porcelli F, Rosen M, Feffer M, Stoner E, New MI, Clinical applications of the rapid high pressure liquid chromatographic determination of serum cortisol.  In: Proceedings of the Eighth International Symposium on Column Liquid Chromatography, J Chromatography, 317:377‑382,1984.
  209. New MI: Hiperplasia adrenal congenita por deficit de 21‑hidroxilasa (forma clasica y variantes).  In: I Rodriquez Rodriguez, A Jimenez Cruz (eds), VI Reunion Nacional de Endocrinologia Pediatrica, November 2‑3, 1984, Puerto de la Cruz, Tenerife, 1984, pp 75‑122.
  210. Mandel FP, Chang RJ, Dupont B, Pollack MS, Levine LS, New MI, Lu JK, Judd HL: HLA genotyping in family members and patients with familial polycystic ovarian disease.  J Clin Endocrinol Metab 56:862‑864, 1983.
  211. Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI: Nonsalt‑losing congenital adrenal hyperplasia due to 3ß‑hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. J Clin Endocrinol Metab 56:808‑818, 1983.
  212. Virdis R, Levine LS, Levy D, Pang S, Rapaport R, New MI: Congenital adrenal hypoplasia: two new cases.  J Endocrinol Invest, 6:51‑54, 1983.
  213. Pang S, Murphey W, Levine LS, Spence DA, Leon A, LaFranchi S, Surve AS, New MI: Newborn screening for congenital adrenal hyperplasia in Alaska.  In: H Naruse, M Irie (eds),  Neonatal Screening, Excerpta Medica International Congress Series 606, 1983, pp 316‑323.
  214. McVie R, Levine LS, New MI: Aldosterone concentration in saliva.  In: GF Read, D Riad‑Fahmy, RF Walker, K Griffiths (eds),  Immunoassay of Steroids in Saliva, Proceedings of the Ninth Tenovus Workshop, Cardiff November 1982, Alpha Omega Publishing, Wales, 1984, pp 295‑299.
  215. Kelch RP, Virdis R, Rapaport R, Greig F, Levine LS, New MI: Congenital Adrenal Hypoplasia.  In: MI New and LS Levine (eds), Adrenal Diseases in Childhood, In: Z Laron (ed), Pediatric and Adolescent Endocrinology, Vol 13, S Karger AG, Basel, 1984, pp 156‑161.
  216. New MI, Dupont B, Pang S, Pollack MS, Levine LS: Enzymatic defects of adrenal steroidogenesis.  In: K Fotherby and SB Pal (eds), Steroid Converting Enzymes and Diseases, Walter de Gruyter and Co, Berlin/New York, 1984, pp 1‑71.
  217. New MI, Levine LS, Temeck JW: Disorders of the adrenal gland, In: SS Gellis and BM Kagan (eds), Current Pediatric Therapy, 11th edition, WB Saunders Co, Philadelphia, 1984, pp 295‑299.
  218. Stoner E, Starkman H, Wellner D, Wellner VP, Sassa S, Rifkind AB, Grenier A, Steinherz PG, Meister A, New MI, Levine LS: Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.  Pediatr Res 18:1332‑1336, 1984.
  219. Stiehm ER, DeVivo DC, Brann Jr AW, Fisher DA, Hodson WA, New MI, Shearer WT, Sokol RJ, Sunshine P and Taeusch Jr HW: Advances in perinatology from the clinical research centers.  Pediatr Res, 18:197‑212, 1984.
  220. New MI, Levine LS, Pang S, Pollack MS, Dupont B: Adrenal components in abnormal sexual differentiation.  In: M Serio, M Motta, M Zanisi, L Martini (eds), Sexual Differentiation: Basic and Clinical Aspects, Raven Press, New York, pp 321‑349, 1984.
  221. Greig F, Oberfield SE, Levine LS, Ghavimi F, Pang S, New MI: Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'‑DDD, Clin Endocrinol 20:389‑399, 1984.
  222. Pang S, New MI: Past, present, and future needs of neonatal screening in congenital disorders and in inborn errors of metabolism.  In: RA Wapnir (ed), Congenital Metabolic Diseases: Diagnosis and Treatment, Marcel Dekker, New York, 1985, pp 85‑102.
  223. Sen S, Bumpus FM, Oberfield SE, New MI: Development and preliminary application of a new assay for aldosterone stimulating factor (ASF).  Hypertension 5 (supp I): I‑27‑I‑31, 1983.
  224. Ehrhardt AA, Meyer‑Bahlburg HFL, Bell JJ, Cohen SF, Healey JM, Stiel R, Feldman JF, Morishima A, New MI: Idiopathic precocious puberty in girls: psychiatric follow‑up in adolescence.  J Am Acad Child Psychiatry 23, 1:23‑33, 1984.
  225. New MI: Hipertension endocrina en la infancia. In: I Rodriquez Rodriguez, A Jimenez Cruz (eds), VI Reunion Nacional de Endocrinologia Pediatrica, November 2‑3, 1984, Puerto de la Cruz, Tenerife, 1984, pp 123‑188.
  226. New MI, Levine LS: Recent advances in 21‑hydroxylase deficiency.  Ann Rev Med, 35:649‑663, 1984.
  227. New MI: Salt‑wasting congenital adrenal hyperplasia.  Pediatr Emergency Casebook, 2:1‑15, 1983.
  228. Levine LS, New MI: Congenital adrenal hyperplasia. In: N Lavin (ed), Manual of Endocrinology and Metabolism, Little Brown and Co, Boston, 1986, pp 143‑161.
  229. Levine LS, Oberfield SE, New MI: Hypertension in childhood.  In: N Lavin (ed), Manual of Endocrinology and Metabolism, Little Brown and Co, Boston, 1986, pp 163‑176.
  230. White PC, New MI, Dupont B: Cloning and expression of cDNA encoding a bovine adrenal cytochrome P‑450 specific for steroid21‑hydroxylation.  Proc Natl Acad Sci USA, 81:1986‑1990, 1984.
  231. New MI: Congenital enzymatic defects of the adrenal.  In: DC Anderson and JSD Winter (eds), Butterworth's International Medical Reviews ‑ Endocrinology; The Adrenal Cortex, Butterworth, London, 1985, pp 120‑153.
  232. Rosenfeld RG, Hintz RL, Johanson AJ, Brasel JA, Burstein S, Chernausek SD, Clabots T, Frane J, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, New MI, Saenger P, Stoner E, Sybert V: Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial.  J Pediatr 6:936-940, l986.
  233. New MI, Oberfield SE, Schneider B, Temeck J, Pang S: Polymorphism of ACTH in hyperaldosteronism and adrenal hyperplasia.  In: D Gupta (ed), Paediatric Neuroendocrinology, Croom Helm Ltd, Kent, 1985, pp 173‑189.
  234. New MI, Temeck J, Grimm R, Pang S: An overview of disorders of sexual differentiation.  Resident and Staff Physician, 31:21‑43, 1985.
  235. New MI: The HLA system in congenital adrenal hyperplasia.  In: CGD Brook and DM Styne (eds), Current Concepts in Pediatric Endocrinology, chap 2, Prager, 1987, pp 28‑61.
  236. New MI: Female pseudohermaphroditism in 21‑hydroxylase deficiency. In: JB Josimovich, JJ Gold, (eds), Gynecologic Endocrinology, 4th Edition, Plenum Press, New York, 1987, pp 327‑347.
  237. Stoner E, Loche S, Mirth A, New MI: Clinical utility of adrenal steroid measurement by high pressure liquid chromatography (HPLC) in pediatric endocrinology.  J Chromatography, 374: 358‑362, 1986.
  238. Fallo F, Oberfield SE, Levine LS, Stoner S, Greig F, New MI, Sniderman K, Saddekni S, Sos TA: Evaluation of percutaneous transluminal renal angioplasty in childhood hypertension.  Int J Ped Neph 6:261‑226, 1985.
  239. New BL, New MI: External genital ambiguity, In: M Farber (ed), Human Sexuality: The Psychosexual Effects of Disease, Macmillan Publishing Company, Inc, New York, 1985, pp 87‑95.
  240. New MI: Low‑renin hypertension in childhood.  In: F Mantero, EG Biglieri, JW Funder, BA Scoggins (eds), The Adrenal Gland and Hypertension, Serono Symposia, vol 27, Raven Press, New York, 1985, pp 319‑336.
  241. White PC, New MI, Dupont B: HLA‑linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P‑450 specific for steroid 21‑hydroxylation.  Proc Natl Acad Sci USA  81:7505‑7509, 1984.
  242. Pang S, Lerner AJ, Stoner E, Levine LS, Oberfield SE, Engel I, New MI: Late‑onset adrenal steroid 3ß‑hydroxysteroid dehydrogenase deficiency I: A cause of hirsutism in pubertal and postpubertal women.  J Clin Endocrinol Metab, 60:428‑439, 1985.
  243. Speiser PW, Stoner E, New M: Pseudohypoaldosteronism: a review and report of two new cases.  In: GP Chrousos, DL Loriaux, and MB Lipsett, (eds), Steroid Hormone Resistance, Plenum Publishing Company, New York, 1986, pp 173‑195.
  244. New MI: An update of congenital adrenal hyperplasia. In: Syllabus of the 36th Annual Postgraduate Assembly of the Endocrine Society, Dallas, Oct 15‑16, 1984, pp 187‑217.
  245. White PC, New MI, Dupont B: Cloning and expression of cDNA encoding a bovine adrenal cytochrome P‑450 specific for steroid 21‑hydroxylation.  In: The Role of Genetic Predisposition in Responses to Chemical Exposures, Banbury Report No 17, Cold Spring Harbor, NY, 1984.
  246. White PC, Dupont B, New MI: Molecular cloning of steroid 21‑hydroxylase. Endocrine Research 10:335‑346, 1985.
  247. White PC, New MI, Dupont B: Molecular cloning of steroid 21‑hydroxylase. Ann NY Acad Sci 458:277‑288, 1985.
  248. White PC, Chaplin DD, Weis JH, Dupont B, New MI, Seidman JG: Two steroid 21‑hydroxylase genes are located in murine S regions.  Nature 312:465‑467, 1985.
  249. Pang S, Spence DA, New MI: Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska. Ann NY Acad Sci, 458:90-102, 1985.
  250. Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI: Pitfalls of prenatal diagnosis of 21‑hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab 61:89‑97, 1985.
  251. Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New M: Pitfalls of prenatal diagnosis of 21‑hydroxylase deficiency congenital adrenal hyperplasia.  Ann NY Acad Sci 458:111‑129, 1985.
  252. Stoner E, DiMartino J, Kuhnle U, Levine LS, Oberfield SE, New MI: Is salt‑wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect?  Clin Endocrinol 24: 9‑20, 1986.
  253. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI: High frequency of nonclassical steroid 21‑hydroxylase deficiency.  Am J Hum Genet, 37:650‑667, 1985.
  254. New MI: Diagnosis and management of ambiguous genitalia in the newborn.  In: IH Porter, N Hatcher, A Willey (eds), Perinatal Genetics, New York, Academic Press, 1986, pp 133‑157.
  255. Speiser PW, Martin KO, Kao‑Lo G, New MI: Excess mineralocorticoid receptor activity in patients with dexamethasone‑suppressible hyperaldosteronism is under adrenocorticotropin control.  J Clin Endocrinol Metab 61:297‑302, 1985.
  256. White PC, Grossberger D, Onufer BJ, New MI, Dupont B, Strominger JL: Two genes encoding steroid 21‑hydroxylase are located near the genes encoding the fourth component of complement in man.  Proc Natl Acad Sci USA 82:1089‑1093, 1985.
  257. Speiser PW, New MI: Genetics of steroid 21‑hydroxylase deficiency.  Trends in Genetics 1:275‑278, 1985.
  258. New MI: Clinical and endocrinological aspects of 21‑hydroxylase deficiency Ann NY Acad Sci 458:1‑27, 1985.
  259. New MI: Genetics of congenital adrenal hyperplasia.  In: CJ Papadatos, CB Bartsocas (eds), Endocrine Genetics and Genetics of Growth, Alan R Liss, Inc, New York, 1985, pp 233‑241.
  260. DiMartino‑Nardi J, Stoner E, O'Connell A, New MI: The effect of treatment on final height in congenital adrenal hyperplasia.  Acta Endocrinol (Suppl. Prader Liber Amicorum) 279:305‑314, 1986.
  261. Van Thiel DH, Gartner LM, Thorp FK, Newman SL, Lindahl JA, Stoner E, New MI, Starzl TE: Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.  J Hepatol 3:42‑48, 1986.
  262. Fallo F, Oberfield SE, Levine LS, Stoner E, Greig F, Sniderman K, Saddekni S, Sos T, New MI: Percutaneous transluminal renal angioplasty in childhood hypertension.  In: IH Slater (ed), Clinical and Experimental Hypertension. In: K Scharer, W Rascher, D Ganten, U Laaser, (eds), Proceedings of the Second International Symposium on Hypertension in Children and Adolescents, Oct 11‑12, 1985, Heidelberg, FRG, Vol A8, No 4,5 Marcel Dekker, New York, 1986, pp 887‑892.
  263. New MI: Premature thelarche and estrogen intoxication.  In: JA McLachlan (ed), Estrogens in The Environment II, Elsevier Science Publishing Co, Inc, New York, 1986, pp 349‑357.
  264. White PC, New MI, DuPont B: Adrenal 21‑hydroxylase cytochrome P‑450genes within the MHC class III region.  Immuno Reviews 87: 123‑150, 1985.
  265. New MI, Levine LS, Temeck JW:  Disorders of the adrenal gland.  In: SS Gellis and BM Kagan (eds), Current Pediatric Therapy, 12th edition, WB Saunders Co, Philadelphia, 1986, pp 308‑312.
  266. Nass R, Petito C, Stoner E, New MI: Neuronal ceroid lipofuscinosis with hypergonadotropic hypogonadism.  J Child Neurology 1:142‑144, 1986.
  267. Ghizzoni L, Muller‑Eberhard U, New MI, Finlayson M, Johnson EF: Characterization by serial biopsy of variations among untreated rabbits in hepatic progesterone 21‑hydroxylase activity.  Biochem Biophysical Comm 130:43‑49, 1985.
  268. New MI, Speiser PW: Genetics of adrenal steroid 21‑hydroxylase deficiency.  Endocrine Rev 7:331‑349, 1986.
  269. National Institutes of Health Consensus Development Conference Statement, (MI New, Panel Member; J Hirsch, Chairman), Health Implications of Obesity. Annals Int Med l03: 147‑l51, 197‑1077, 1985.
  270. Temeck J, Pang S, Nelson C and New MI: Genetic defect of steroidogenesis in premature pubarche.  J Clin Endocrinol Metab 64:609‑617, 1987.
  271. New MI: Adrenal: Review of anatomy, biochemistry and physiology; CAH: Genetics, clinical variants, diagnosis and management.  Syllabus, Current Review of Pediatric Endocrinology, Serono Symposia, Wash DC, May 1‑4,1986.
  272. Loche S, Rifkind AB, Stoner E, Faedda A, Garabedian MC, New MI: Microfilter paper method for antipyrine determination in whole blood by high pressure liquid chromatography.  Thera Drug Monit 8:214‑218, 1986.
  273. New MI: Update on congenital adrenal hyperplasia. In: 37th Ann Postgraduate Assembly - Endocrine Soc Syllabus, Miami, Oct 14‑18, 1985.
  274. Stoner E, New MI: Hypertensive disorders of childhood. In: DT Minenberg, (guest editor), Hypertension in Childhood.  In: RM Ehrlich, (ed), Dialogues in Pediatric Urology, Wm J Miller Associates, Pearl River NY, 1985, pp 2‑4.
  275. DiMartino‑Nardi J, New MI: Low‑renin hypertension.  Pediatr Nephrol 1:99‑108, 1987.
  276. New MI: Hypertension, its treatment, and involvement of endocrine glands.  In: L Cavallo, G Chiumello, DB Grant, MI New, F Schettini (eds), International Symposium, Endocrine Involvement in Chronic Diseases in Children, Arti Grafiche Defa, Milano, 1986, pp 119‑125.
  277. Dupont B, Virdis R, Lerner AJ, Pollack MS, New MI: Distinct HLA‑B antigen associations for the salt‑wasting and simple virilizing forms of congenital adrenal hyperplasia due to 21‑hydroxylase deficiency.  In: ED Albert, MP Baur, WR Mayr (eds), Histocompatibility Testing 1984, Springer‑Verlag, Berlin, 1984, p 660.
  278. New MI, Stoner E, DiMartino‑Nardi J: Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.  In: IH Slater (ed), Clinical and Experimental Hypertension.  In: K Scharer, W Rascher, D Gantern, U Laaser (eds), Proceedings of the Second International Symposium on Hypertension in Children and Adolescents, Oct 11‑12, 1985, Heidelberg, FRG, Vol A8, No 4,5, Marcel Dekker, NY, 1986, pp 751‑772.
  279. Loche S, Rifkind AB, Conney AH, Stoner E, New MI: Antipyrine clearance in congenital adrenal hyperplasia.  Clin Endocrinol 25:233‑239, 1986.
  280. Dupont B, Pollack MS, New MI:  Disease susceptibility genes in the HLA complex.  Banbury Report 16: 1984, pp 297‑307.
  281. Speiser PW, Martin KO, DiMartino‑Nardi J, Stoner E, New MI: Excess mineralocorticoid receptor activity in patients with dexamethasone‑suppressible hyperaldosteronism is under adrenocorticotropin control.  In: MI New and P Borelli (eds), Dexamethasone‑Suppressible Hyperaldosteronism, Serono Symposia Review No 10, Ares‑Serono Symposia, Rome, Italy, l986, pp 60‑68.
  282. White PC, New MI, Dupont B: Genetics of HLA‑linked congenital adrenal hyperplasia.  In: B Blomberg et al (eds), Advances in Gene Technology: Molecular Biology of the Immune System, New York, Cambridge University Press, 1985, pp 41‑45.
  283. Ludvigsson J, Samuelsson U, Beauforts C, Deschamps I, Dorchy H, Drash A, Francois R, Herz G, New M, Schober E:  HLA‑DR3 is associated with a more slowly progressive form of Type I (insulin‑dependent) diabetes.  Diabetologia, 29:207‑210, 1986.
  284. White PC, Werkmeister J, New MI, Dupont B: Steroid 21‑hydroxylase deficiency and the major histocompatibility complex.  Hum Immunol 15:404‑415, 1986.
  285. Werkmeister JW, New MI, Dupont B, White PC: Frequent deletion and duplication of the steroid 21‑hydroxylase genes.  Am J Hum Genet 39:461‑469, 1986.
  286. Cappa M, Stoner E, DiMartino J, Pang S, Temeck J, Gudmundsson ST, New, MI: Heterogeneity of Cushing's disease in childhood.  J Pediatr Neurosci 2:11‑26, 1986.
  287. Monder C, Shackleton CHL, Bradlow HL, New MI, Stoner E, Iohan F, Lakshmi V: The syndrome of apparent mineralocorticoid excess: its association with 11ß‑dehydrogenase and 5a‑reductase deficiency and some consequences for corticosterone metabolism, J Clin Endocrinol Metab 63:550‑557, 1986.
  288. Stoner E, Noto RA, Oberfield SE, Levine LS, New MI: Effect of acute dietary sodium alterations in normotensive and hypertensive children.  J Pediatr Endocrinol 2:81‑88, 1987.
  289. White PC, New MI, Dupont B: Structure of human steroid 21‑hydroxylase genes.  Proc Natl Acad Sci USA, 83:5111‑5115, 1986.
  290. Speiser PW, New MI: Genotype and hormonal phenotype in nonclassical 21‑hydroxylase deficiency, J Clin Endocrinol Metab 64:86‑91, 1987.
  291. Cappa M, Stoner E, DiMartino‑Nardi J, Pang S, Temeck J, New MI: Recurrence of Cushing's disease in childhood after radiotherapy‑induced remission Am J Dis Children 141: 736‑740, 1987.
  292. New MI: Clinical and biochemical spectrum of congenital adrenal hyperplasia: new molecular insights.  In:  R D'Agata, GP Chrousos (eds), Recent Advances in Adrenal Regulation and Function, Serono Symposia, Madrid, Spain, Sept 19‑20, 1986, Raven Press, New York, 1987, pp 171‑174.
  293. New MI: Basic, clinical aspects of congenital adrenal hyperplasia Proceedings of the VII International Congress on Hormonal Steroids, Madrid, Spain, Sept 21, 1986.  J Steroid Biochem 27:1‑7, 1987.
  294. Nass R, Baker S, Speiser P, Virdis R, Balsamo A, Cacciari E, Loche S, Dumic M, New MI: Hormones and handedness: Left-hand bias in female congenital adrenal hyperplasia patients. Neurology 37:711‑715, 1987.
  295. Committee of the Second International Symposium on Hypertension in Children, (MI New, Committee Member) Recommendations for blood pressure measurement in children and adolescents.  In: IH Slater (ed), Clinical and Experimental Hypertension.  In: K Scharer, W Rascher, D Gantern, U Laaser (eds), Proceedings of the Second International Symposium on Hypertension in Children and Adolescents, Oct 11‑12, 1985, Heidelberg, FRG, Vol A8, No 4, 5, Marcel Dekker, New York, 1986, pp 901‑918.
  296. Lahita RG, Bradlow HL, Ginzler E, Pang S, New MI: Low plasma androgens in women with systemic lupus erythematosus.  Arthr Rheumat 30:241‑248, 1987.
  297. New MI: HLA and adrenal disease.  In: NR Farid (ed), Immunogenetics of Endocrine Disorders, Alan R Liss, New York, 1988, pp 309‑344.
  298. Drucker S, Speiser PW, New MI: Hereditary aspects of defects in synthesis of adrenal hormones.  In: DR Hollingsworth and R Resnik (eds), Medical Counseling Before Pregnancy, Churchill, Livingstone, New York, 1988, pp 193‑209.
  299. New MI: Molecular genetics and the characterization of steroid 21‑hydroxylase deficiency.  Endocrine Res 12:505‑522, 1986.
  300. Nass R, Engel M, Stoner E, Pang S, New MI: Empty sella syndrome in childhood. Pediatr Neurol 2:224‑228, 1986.
  301. Drucker S, New MI: Disorders of adrenal steroidogenesis. Ped Clin N Am 34: 1055‑1066, 1987.
  302. Drucker S, New MI: Nonclassic adrenal hyperplasia due to 21‑hydroxylase deficiency.  Ped Clin No Amer 34:1067‑1081, 1987.
  303. Pang S, New MI: Pitfalls of prenatal diagnosis of 21‑hydroxylase deficiency congenital adrenal hyperplasia.  In: BL Therrell Jr (ed), Advances in Neonatal Screening.  In: Excerpta Medica International Congress Series 741, Amsterdam, 1987, pp 273‑278.
  304. Pang S, Softness B, Sweeney WJ III, New MI: Hirsutism, polycystic ovarian disease, and ovarian l7‑ketosteroid reductase deficiency. New Engl J Med 316:1295‑1301, 1987.
  305. DiMartino‑Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI: New findings in apparent mineralocorticoid excess.  Clin Endocrinol 27:49‑62, 1987.
  306. Zerah M, Pang S, New MI: Morning salivary l7‑hydroxyprogesterone is a useful screening test for nonclassical 21‑hydroxylase deficiency.  J Clin Endocrinol Metab 65:227‑232, 1987.
  307. Pang S, Legido A, Levine LS, Temeck JW, New MI: Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin‑releasing hormone stimulation in children with hypopituitarism.  J Clin Endocrinol Metab 65: 282‑289, 1987.
  308. Döhler K‑D, New MI: Sexualentwicklung.  In: RD Hesch (ed), Innere  edizin der Gegewnwart, vol IV: Endokrinologie,  Urban and Schwarzenberg, München, 1989, pp 501-512.
  309. Temeck J, Pang S, New MI:  Congenital adrenal hyperplasia.  In: W Bardin (ed), Current Therapy in Endocrinology and Metabolism, 3rd edition, BC Decker Inc, Philadelphia, 1988, pp 143-48.
  310. New MI, Drucker S, Speiser P: Nonclassical steroid 21‑hydroxylase deficiency as a cause of reproductive dysfunction. In: SS Wachtel (ed), Evolutionary Mechanisms in Sex Determination,  CRC Press, Florida, 1989, pp 253-264.
  311. White PC, New MI, Dupont B: Congenital adrenal hyperplasia.  New Engl J Med 316:1519‑1524, 1580‑1586, 1987.
  312. New MI, Speiser PW: Congenital adrenal hyperplasia, In: CGD Brook (ed), Clinical Paediatric Endocrinology, Blackwell Scientific, Oxford, 1989, pp 441-462.
  313. Sasano H, White PC, New MI, Sasano N: Immunohistochemistry of cytochrome P‑450 21‑hydroxylase: microscopic examination of the enzyme in the bovine adrenal cortex and kidney.  Endocrinology 122:291‑295, 1988.
  314. New MI, White PC, Pang S, Dupont B, Speiser PW: The adrenal hyperplasias, In: CR Scriver, AL Beaudet, WS Sly and D Valle (eds), The Metabolic Basis of Inherited Disease, 6th edition, McGraw‑Hill, New York, 1989, pp 1881-1917.
  315. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI: A segregation and linkage study of classical and nonclassical 21‑hydroxylase deficiency.  Am J Hum Genet 42:830‑838, 1988.
  316. Aston CE, Sherman SL, Morton NE, Speiser PW, New MI: Genetic mapping of the 21‑hydroxylase locus: estimation of small recombination frequencies.  Am J Hum Genet 43:304-10, 1988.
  317. Amor M, Parker KL, Globerman H, New MI, White PC: Mutation in the CYP21 gene Ile-172 causes steroid 21‑hydroxylase deficiency.  Proc Natl Acad Sci USA 85:1600-1604, 1988.
  318. Globerman H, Amor M, Parker KL, New MI, White PC: A nonsense mutation causing steroid 21‑hydroxylase deficiency.  J Clin Invest 82:139-44, 1988.
  319. New MI: Congenital adrenal hyperplasia. Biochem Soc Trans 16:691-694, 1988.
  320. New MI, Speiser PW:  Disorders of adrenal steroidogenesis.  In: ED Vaughan and RM Carey, (eds), Adrenal Disorders, New York, Thieme Medical, 1989, pp 191-217.
  321. New MI, Crawford C:  Low renin hypertension in childhood.  In: F Lifshitz (ed), Pediatric Endocrinology, 2nd Ed, New York, Marcel Dekker, 1990, pp. 921-935.
  322. Speiser PW, New MI:  An update of congenital adrenal hyperplasia. In: F Lifshitz (ed), Pediatric Endocrinology, 2nd Ed, New York, Marcel Dekker, 1990, pp. 307-331.
  323. New MI, Brown P, Temeck JW, Owens C, Hedley‑Whyte ET, Richardson EP: Preclinical Creutzfeldt‑Jakob disease discovered at autopsy in a human growth hormone recipient.  Neurology 7:1133-4, 1988.
  324. White, PC, Vitek A, Dupont B, New MI: Characterization of frequent deletions causing steroid 21‑hydroxylase deficiency.  Proc Nat Acad Sci USA 85:4436‑4440, 1988.
  325. New MI, Nemery RL, Chow DM, Kaufman ED, Stoner E, Zerah M, Crawford C, Speiser PW: Low‑renin hypertension of childhood.  In: F Mantero, R Takeda, BA Scoggins, EG Biglieri,  JW Funder (eds), The Adrenal and Hypertension: from Cloning to Clinic.  Ares‑Serona Symposia, No 57, Tokyo, July 25‑26, 1988, Raven Press, New York, 1989, pp 323-343.
  326. Speiser PW, New MI, White PC:  Molecular genetic analysis of nonclassic steroid 21‑hydroxylase deficiency associated with HLA‑B14;DR1.  New Engl J Med 319:19-23, 1988.
  327. New MI, White PC, Speiser PW, Crawford C, Dupont B: Congenital adrenal hyperplasia.  In: CRW Edwards and DW Lincoln, eds.  Recent Advances in Endocrinology and Metabolism, vol 3, New York, Churchill, Livingstone, 1989, pp 29-76.
  328. New MI, White PC, Dupont B, Crawford C, Speiser PW: Congenital adrenal    hyperplasia.  In: Endocrinology and Metabolism In‑Service Training and Continuing Education Program.  Washington DC, The American Association for Clinical Chemistry, vol 6, 1988, pp 5‑19.
  329. New MI, White PC, Speiser PW, Crawford C, Dupont B: Congenital adrenal hyperplasia.  In: AEH Emery and DL Rimoin (eds), Principles and Practice of Medical Genetics, 2nd Ed., New York, Churchill, Livingstone, 1990, pp 1559-1591.
  330. Anderson KE, Rosner W, Khan MS, New MI, Pang S, Wissel PS, Kappas A:        Diet‑hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man.  Life Sciences 40: 1761‑1768, 1988
  331. New MI, Josso N: Disorders of gonadal differentiation and congenital adrenal hyperplasia.  In: WF Young Jr and GG Klee (eds), Diagnostic Evaluation of Endocrine Disorders.  In: Endocrinology and Metabolism Clinics of North America, vol. 17, WB Saunders Co, Philadelphia, 1988, pp 339‑366
  332. New MI, White PC, Speiser PW.  Congenital adrenal hyperplasia. In: J Martinez-Mora and L Audi (eds), Intersexuality States, 1993.
  333. Britton H, Shebab Z, Lightner E, New M, Chow D:  Adrenal response in children receiving high doses of ketoconazole for systemic coccidioidomycosis.  J Pediatr 112:488‑92, 1988.
  334. New MI, Gertner JM, Speiser PW, del Balzo P:  Growth and final height in classical and nonclassical 21‑hydroxylase deficiency.  Acta Paediatr Jpn 30: 79-88, 1989.
  335. Globerman H, Rösler A, Theodor R, New MI, White PC: An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11‑hydroxylase.  N Engl J Med 319:1193‑1197, 1988.
  336. New MI: Optimal treatment of adrenogenital syndrome.  In: Syllabus of The Endocrine Society 40th Annual Postgraduate Assembly, Phila, Pa, 1988, p 272-289.
  337. Sasano H, White PC, New MI, Sasano N:  Immunohistochemical localization of cytochrome P‑450C21 in human adrenal cortex and its relation to endocrine function.  Human Pathology 19:181-5, 1988.
  338. Speiser PW, New MI, White PC:  Clinical and genetic characterization of nonclassic 21‑hydroxylase deficiency.  Endocrine Res 15: 257-276, 1989.
  339. Globerman H, Pang S, Selfe RW, New MI, Grabowski E, Feliz J, Hurley JR:  Eosinophilic granuloma presenting as hypothyroidism and goiter.  J Pediatr Endocrinol 3:181-184, 1989.
  340. Speiser  PW, Stoner E, White PC, Crawford C, New MI:  Steroid modulation of blood pressure and mineralocorticoid hypertension. In: JMH Loggie (ed), Pediatric and Adolescent Hypertension,  Chap 5, Blackwell Scientific Publications, Cambridge, 1992, pp 64-73.
  341. New MI, White PC, Speiser PW, Crawford C, Dupont B: Genetic disorders of adrenal hormone  synthesis.  In: Proceedings of the 8th International Congress of Endocrinology, Kyoto, 17-23 July 1988.  Excerpta Medica, Intnl Congr Ser, vol 799: Amsterdam, Elsevier pp 55-72, 1988.
  342. New MI, del Balzo P, Crawford C, Speiser PW:  The adrenal cortex. In: SA Kaplan (ed), Clinical Pediatric and Adolescent Endocrinology,  Philadelphia, WB Saunders, 1989, pp 181-234.
  343. New MI, Speiser PW, Crawford C, White PC:  Inborn errors of steroidogenesis.  In: JR Pasqualini, R Scholler (eds), Hormones and Fetal Physiology,  New York, Marcel Dekker, 1992, pp 1-51.
  344. New MI, del Balzo P, Schnakenburg KV: Diseases of the anterior and posterior pituitary. In: H Eichenwald, J Stroder (eds), Current Therapy in Pediatrics, vol 2, BC Decker, Burlington, Ontario, 1988, pp 223-225.
  345. New MI, del Balzo P, Schnakenburg KV: Disorders of the adrenal.  In: H Eichenwald, J Stroder (eds), Current Therapy in Pediatrics, vol 2, BC Decker, Burlington, Ontario, 1988, 217‑223.
  346. New MI:  Polycystic ovarian disease and congenital and late‑onset adrenal hyperplasia.  In: JK Mahajan (ed), Polycystic Ovarian Disease,  In: Endocrinol Metab Clin North Am 17: 637-648, 1988.
  347. New MI, Gertner JM, Speiser PW, del Balzo P:  Final height in classical and nonclassical 21-hydroxylase deficiency adrenal hyperplasia.  In: JR Bierich, E Cacciari, S Raiti (eds),  Growth Abnormalities, vol. 56. Serono Symposia, Bologna, June 1988, Raven Press, 1989, pp 51-61.
  348. White PC, New MI:  Molecular genetics of congenital adrenal hyperplasia.  In: M Sheppard (ed), Molecular Biology of Endocrinology,  In:  Bailliere's Clinical Endocrinology and Metabolism, vol 2, WB Saunders/Bailliere Tindall, London, 1988, pp 941-965.
  349. Shulman DI, Vargas A, Rodriguez, Steinberger E, New MI, Root AW, Bercu BB:  Male pseudohermaphroditism and hypertension due to 17a‑hydroxylase deficiency:  seven year follow up and in vitro studies of testicular tissue.  J Ped Endocrinol 2:89-95, 1987.
  350. Speiser PW, White PC, New MI: Disorders of adrenal steroidogenesis. In: RA King, JI Rotter, AG Motulsky (eds), Chap 24. The Genetic Basis of Common Diseases, Oxford University Press, New York, 1992, pp 529-550.
  351. New MI:  Adrenal hyperplasia and endocrine infertility.  In: Endocrinology and Infertility Update:  Current Trends and New Horizons.  Conference sponsored by Columbia University and Sloane Hospital for Women, The Presbyterian Hospital.  New York,  March 30-Apr 1, 1989, pp  221-238.
  352. New MI:  Disturbi della corteccia surrenale in adulti e bambini.  Leadership Medica (Milan) 4: 4‑8, 1988.
  353. Rosenfeld RG, Hintz RL, Johanson AJ, et al.:  Results from the first 2 years of a clinical trial with recombinant DNA‑derived human growth hormone (somatrem) in Turner's syndrome.  Acta Paediatr Scand [Suppl] 331:59, 1987.
  354. Wilson DM, Frane JW, Sherman B, Johanson J, Hintz RL, Rosenfeld RG, Brasel J, Burstein S, Chernausek SD, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V:  Carbohydrate and lipid metabolism in Turner syndrome:  effect of therapy with growth hormone, oxandrolone, and a combination of both.  J Pediatrics 112:210-217, 1988.
  355. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, Frane J, Gotlin DW, Kuntze J, Lippe RM, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V:  Three‑year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.  J Pediatrics 113: 393-400, 1988.
  356. Burstein S, Crawford C, New MI:  Congenital adrenal hyperplasia:  female pseudohermaphroditism and virilization.  In: L Speroff and JL Simpson (eds),  Reproductive Endocrinology, Infertility, Genetics,  Vol. 5, Series 55, In: JJ Sciarra (ed), Gynecology and Obstetrics, Chap 78, JB Lippincott Co, Phila, 1991. pp 1-21.
  357. New MI, Gertner JM, Speiser PW, del Balzo P:  Growth and final height in classical and nonclassical 21‑hydroxylase deficiency.  J Endocrinol Invest 12:91-95, 1989.
  358. White PC, Crawford C, New MI:  Steroid 21-hydroxylase deficiency, Current Opinion in Pediatrics 1: 436-440, 1989.
  359. Speiser PW, Laforgia N, Kato K, Pareira J, Khan R, Yang SY, Whorwood C, White PC, Elias S, Schriock E, Schriock E, Simpson JL, Taslimi M, Najjar J, May S, Mills G, Crawford C, New MI:  First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21‑hydroxylase deficiency).  J Clin Endocrinol Metab 70:838-848, 1990.
  360. Zerah M, Ueshiba J, Wood E, Speiser P, Crawford C, McDonald T, Pareira J, Gruen D, New MI:  Prevalence of nonclassical steroid 21‑hydroxylase deficiency based on a morning salivary 17‑hydroxyprogesterone screening test:  a small sample study.  J Clin Endocrinol Metab 70:1662-1667, 1990.
  361. Burstein S, New MI: Commentary.  Pediatr Infect Dis J 8:19-20, 1989.
  362. White PC, New MI, Dupont B:  Congenital adrenal hyperplasia.  (Letter to the Editor) New Engl J Med 317: 1413-1415, 1987.
  363. New MI, Karaviti L:  Congenital adrenal hyperplasia.  In: CW Bardin (ed), Current Therapy in Endocrinology and Metabolism, BC Decker Inc, Philadelphia, 1991, pp 141-151.
  364. New MI:  Nonclassical 21‑hydroxylase deficiency.  In: Polycystic Ovary Syndrome, In: A Dunaif, J Givens, G Merriam, FP Haseltine (eds), Current Issues in Endocrinology and Metabolism Series,  Blackwell Scientific, Cambridge, 1992, pp 145-161.
  365. Speiser PW, Levine LS, New MI:  Essential hypertension in childhood and adolescence.  In: JJ Laragh, E Sonnenblick, S Scheidt (eds), Cardiovascular Reviews & Reports, "Classics of the Decade Series", 1990, pp 10-42.
  366. New MI:  Congenital adrenal hyperplasia.  In: RB Conn (ed), Current Diagnosis 8, WB Saunders, Phila, 1991, pp 876-881.
  367. New MI:  Nonclassical 21‑hydroxylase deficiency.  In:  Proceedings of the RM Goodman International Conference,  Israel June 1990.  In: B Bonne-Tamir, A Adam (eds), Genetic Diversity among Jews.  Diseases and Markers at the DNA Level, Chap. 14, Oxford University Press, London, 1992, pp 154-169.
  368. New MI:  Nonclassical 21‑hydroxylase deficiency.  In: EY Adashi, S Mancuso (eds), Major Advances in Human Female Reproduction, vol. 73.  Ares Serono Symposia, Raven Press, New York, 1990, pp 309-315.
  369. New MI, Gertner JM, Speiser PW, del Balzo, P.  Growth and final height in adrenal steroid 21-hydroxylase deficiency.  In: C LaCauza, (ed), Diagnosis and Treatment of Short Stature, May 25-26, 1990, Florence, 1990, Serono Symposia, 1993.
  370. Ulick S, Chan CK, Gill JR, Gutkin M, Letcher L, Mantero F, New MI:  Defective fasciculata zone function as the mechanism of glucocorticoid remediable aldosteronism.  J Clin Endocrinol Metab 71: 1151-1157, 1990.
  371. Pang S, Levine LS, New MI:  Puberty in congenital adrenal hyperplasia.  In:  M Grumbach (ed), Control of the Onset of Puberty II.  Williams & Wilkins, Baltimore, 1990, pp 669-689.
  372. Dumic M, Brkljacic L, Speiser PW, Wood E, Crawford C, Plavsic V, Baniceviac M, Radmanovic S, Radica A, Kastelen A, New MI:  An update on the frequency of nonclassic deficiency of adrenal 21‑hydroxylase in the Yugoslav population.  Acta Endocrinologica 122: 703-710, 1990.
  373. New MI:  Prenatal diagnosis and treatment of adrenogenital syndrome (steroid 21‑hydroxylase deficiency).  Dev Pharmacology Ther 15: 200-210, 1990.
  374. Moya FR, Grannum PAT, Riddick L, Copel JA, Robert JA, Pinheiro J, New MI:  Atrial natriuretic factor in hydrops fetalis due to Rh isoimmunization.  Arch Dis Childh 65:863-868, 1990.
  375. New MI:  Congenital adrenal hyperplasia.  Trans Am Clin Climatol Assoc 102:108-122, 1991.
  376. New MI, Zerah M, Crawford C:  Adrenal function and chronic anovulation. In:  Chronic Hyperandrogenic Anovulation, (Proceedings of the First Organon Symposium, Oss Netherlands Oct 9-10, 1989, Parthenon Publishing Group, Park Ridge NJ, 1991, pp 47-54.
  377. Speiser PW, Agdere L, Ueshiba H, White PC, New MI:  Aldosterone synthesis in salt‑wasting congenital adrenal hyperplasia with complete absence of adrenal 21‑hydroxylase.  New Engl J Med 324: 145-9, 1991.
  378. Zerah M, Schram P, New MI:  The diagnosis and treatment of nonclassical 3b‑HSD deficiency.  The Endocrinologist 1: 75-81, 1991.
  379. New MI:  Congenital adrenal hyperplasia and reproduction.  In: (Syllabus) Frontiers in Reproductive Endocrinology, Serono Symposia, USA, April 22-26, 1991, pp 49-59.
  380. New MI, Karaviti LP, Crawford C:  Disorders of the adrenal gland.  In: FD Burg, JR Ingelfinger, ER Wald (eds),  Current Pediatric Therapy 14, WB Saunders, Philadelphia,  1993, pp 292-296.
  381. Tusie‑Luna MT, Speiser PW, Dumic M, New MI, White PC:  A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21‑hydroxylase deficiency allele.  Mol Endoc 5: 685-692, 1991.
  382. Speiser PW, Serrat J, New MI, Gertner J:  Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.  J Clin Endocrinol Metab 75: 1421-1424, 1992.
  383. Tannin GM, Agarwal AK, Monder C, New MI, White PC:  The human gene for 11b-hydroxysteroid dehydrogenase.  Structure, tissue distribution and chromosomal localization.  J Biol Chem 266: 16653-16658, 1991.
  384. Speiser PW, White PC, New MI:  Congenital adrenal hyperplasia.  In:  VHT James (ed), Comprehensive Endocrinology - The Adrenal Gland, 2nd edition, Raven Press, New York, 1992, pp 327-371.
  385. New MI, Speiser PW, Butenandt O:  Diseases of the anterior and posterior pituitary.  In:  HF Eichenwald, J Ströder, (eds), Current Therapy in Pediatrics - 3,  Mosby-Year Book, St Louis, 1993, pp 261-263.
  386. New MI, Speiser PW, Butenandt O:  Diseases of the adrenals.   In: HF Eichenwald, J Ströder, (eds),  Current Therapy in Pediatrics - 3,  Mosby-Year Book, St Louis, 1993, pp 252-261.
  387. White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rösler A:  A mutation in CYP11B1 (Ar-448-His) associated with steroid 11b-hydroxylase deficiency in Jews of Moroccan origin.  J Clin Invest 87: 1664-1667, 1991.
  388. White PC, New MI:  Genetic basis of endocrine disease 2.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.   J Clin Endocrinol Metab 74: 6-11, 1992.
  389. Schram P, Zerah M, Mani P, Jewelewicz R, Jaffe S, New MI:  Nonclassical 3b-HSD deficiency:  A review of our experience with 25 female patients.  Fertil Steril 58: 129-136, 1992.
  390. Karaviti LP, Mercado AB, Mercado MY, Speiser PW, Buegeleisen M, Crawford C, Antonian L, White PC, New MI:  Prenatal diagnosis/treatment in families at risk for infants with steroid 21‑hydroxylase deficiency (congenital adrenal hyperplasia).  In:  Recent Advances in Steroid Biochemistry and Molecular Biology, (10th Intnl Symposium, May, 1991, France.   J Steroid Biochem and Mol Biol 41: 445-451, 1992.
  391. New MI:  Congenital adrenal hyperplasia.  The Endocrine Society 43rd PostGraduate Assembly Syllabus, pp 270-293, 1992.
  392. New MI, Gertner JM, Speiser PW, del Balzo P:  Growth and final height in congenital adrenal hyperplasia (classical 21-hydroxylase deficiency) and in nonclassical 21-hydroxylase deficiency.  In:  L Cavallo, JC Job, MI New (eds), Growth Disorders: The State of the Art, vol. 81,  Raven Press, New York, 1991, pp 105-110.
  393. Harbison MD, Magid ML, Josso N, Minenberg DT, New MI:  Anti-Müllerian hormone in three intersex conditions.  Ann Genet 34: 226-232, 1991.
  394. Lorberboym M, Sarkar SD, Speiser P, Tannin G, New MI:  Bilateral adrenal uptake of gallium-67 citrate in a patient with congenital adrenal hyperplasia.  Clin Nucl Med 15:849, 1990.
  395. Speiser PW, New MI, Tannin GM, Pickering D, Yang Sy, White PC:  Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  Hum Genet 88: 647-648, 1992.
  396. Speiser PW, Dupont J, Zhu D, Serrat G, Buegeleisen M, Tusie-Luna M-T, Lesser M, New MI, White PC:  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  J Clin Invest 90: 584-595, 1992.
  397. Johnson V, New MI:  If the stimulus to pituitary thyroid-stimulation hormone (TSH) secretion is the lack of circulating free thyroxine, why may a baby with congenital nephrotic syndrome present with a raised TSH on neonatal screening?  Pediatr Nephrolog 6:458, 1992.
  398. New MI:  Pathophysiology of adrenal steroidogenesis. In:  P Gluckman, M A Heyman (eds) Perinatal and Pediatric Physiology - a Clinical Perspective, 1st edition, Hodder and Stoughton Ltd, London, 1993, pp.326-329.
  399. New MI:  Genetic disorders of adrenal hormone synthesis.  In: Proceedings,  International Symposium - Endocrinology and Development, Basic and Clinical Aspects, Athens, Oct 1990, Hor Res 37: 22-33. 1992.
  400. New MI:  The variants of adrenal hyperplasias.  In:  Reproductive Medicine, G Frajese, E Steinberger, LJ Rodriguez-Rigau (eds), Proceedings of the Third International Symposium on Reproductive Medicine, Malta, April, 1992, Ares Serona Symposium Series, Raven Press, pp 173-184, 1993.
  401. Speiser PW, White PC, New MI:  Congenital adrenal hyperplasia.  In:  SK Smith (ed), Reproductive Medicine Review, vol. 2, Hodder & Stoughton, Kent UK, pp 1-13, 1993.
  402. Speiser PW, Riddick LM, Martin K, New MI:  Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.  Metabolism 42: 843-845, 1993.
  403. Ueshiba J, Zerah M, New MI:  Enzyme-linked immunosorbent assay (ELISA) method for screening of non-classical steroid 21-hydroxylase deficiency. Horm Metab Res 26: 43-45, 1994.
  404. New, MI:  Congenital virilizing adrenal hyperplasia.  In:  EY Adashi, JA Rock, Z Rosenwaks (eds), Reproductive Endocrinology, Surgery, and Technology,  Raven Press, New York, 1996, pp 1555-1569. 
  405. New MI:  Prenatal diagnosis and management of congenital adrenal hyperplasia.  In:  Proceedings of the International Sardinian Congr. on Pediatric Endocrinology, Porto Cervo, Oct. 1990.  In:  C Pintor, S Loche, EE Muller, MI New, (eds),  Advances in Pediatric Endocrinology, Springer Verlag, Berlin, 1992, pp 13-16.
  406. Speiser PW, New MI, White PC:  Congenital Adrenal Hyperplasia.  In: RD Weintraub (ed), Molecular Endocrinology:  Basic Concepts and Clinical Correlations.  Raven Press, New York, pp 455-472, 1994.
  407. Kidd K, Kidd JR, Bonné-Tamir B, New MI:  Nuclear DNA polymorphisms and population relationships.  In:  Proceedings of the RM Goodman International Conference,  Israel June 1990.  In: B Bonne-Tamir, A Adam (eds), Genetic Diversity among Jews.  Diseases and Markers at the DNA Level, Chap. 2, Oxford University Press, London, 1992, pp 33-44.
  408. Carré-Eusebe D, Imbeaud S, Harbison M, New MI, Josso N, Picard J-Y:  Variants of the anti‑Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his family.  Human Genetics 90: 389-394, 1992.
  409. New MI:  Female pseudohermaphroditism.  In: N Charest (ed), Sexual Differentiation. In: BK Creasy and JB Warshaw (eds), Seminars in Perinatology, vol 16, WB Saunders Co, Philadelphia, pp 299-318, 1992.
  410. Rhéaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F:  Congenital adrenal hyperplasia due to point mutations in the type II 3b-hydroxysteroid dehydrogenase gene.  Nature Genetics 1:239-245, 1992.
  411. New MI:  Minireview: 21-hydroxylase deficiency congenital adrenal hyperplasia.  J Ster Biochem Molec Biol 48: 15-22, 1994.
  412. New MI:  Nonclassical congenital adrenal hyperplasia and PCO.  In:  Chrousos GP, et al (eds), Intraovarian Regulators and Polycystic Ovarian Syndrome: Recent Progress on Clinical and Therapeutic Aspects.  Proceedings of the Satellite Symposium to  the 9th International Congress of Endocrinology, Aug 24-26, 1992, Athens, Greece.  Ann NY Acad Science, 687: 193-205, 1993.
  413. Simard J, Rhéaume E, Sanchez R, deLaunoit, Laflamme N, Luu-The V, van Seters A, Gordon RD, Heinrich U, Moshang T, New MI, Labrie F: Molecular basis of congenital adrenal hyperplasia due to 3b-hydroxysteroid dehydrogenase deficiency.  Molecular Endocrinology 7:716-728, 1993.
  414. New MI, Kitzinger ES:  Pope Joan: A recognizable syndrome.  J Clin Endo Metab 76: 3-13, 1993.
  415. New MI:  Congenital adrenal hyperplasia.  In:  LJ DeGroot, M Besser, HG Burger, JL Jameson, DL Loriaux, JC Marshall, WD Odell, JT Potts Jr, AH Rubenstein (eds), Endocrinology, 3rd edition, W.B. Saunders Co, Philadelphia, 1995 pp 1813-1835.
  416. New MI:  Pope Joan: A recognizable syndrome.  Trans Am Clin Climatol Assoc, 104: 104-122, 1993.
  417. Nikkilä H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC:  Defects in the HSD11 gene encoding 11b-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.  J Clin Endocrinol Metab 77:687-691, 1993
  418. Pascoe L, Curnow KM, Slutsker L, Connell JMC, Speiser PW, New MI, White PC:  Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.  Proc Natl Acad Sci USA 89:8327-8331, 1992.
  419. Kalaitzoglou G, New MI: Congenital Adrenal Hyperplasia: Molecular Insights Learned from Patients.  University of California at Riverside Symposium on Cellular and Molecular Endocrinology, March 1993, AW Norman, Guest Editor, Receptor  3: 211-222, 1993.
  420. Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L:  Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8.  Proc Natl Acad Sci USA 90:4552-4556, 1993.
  421. Antonian L, Rittmaster RS, Davis EA, Ma Y, New MI, Stoner E:  Chromatographic profile of 3H-finasteride, a 5a-reductase inhibitor, on Abraham's system columns.  Clin Chem News 19: 17-18, 1993.
  422. New MI, Crawford C:  Molecular genetics of steroid 21-hydroxylase deficiency.  In: S Wachtel (ed),  Molecular Genetics of Sex Determination, Chap 17, Academic Press, New York, 1994, pp 399-438.
  423. Rittmaster RS, Antonian L, New MI, Stoner E:  Effect of finasteride on adrenal steroidogenesis in men.  J Andrology 15: 298-301, 1994.
  424. New MI, Tannin G, Curtis JA, Vogiatzi M:  Enzyme defects and adrenal insufficiency.  In:  H R Bhatt,  VHT James, GM Besser, GF Bottazzo, H Keen (eds), Advances in Thomas Addison's Diseases,  J Endocrinology Ltd, 1994, pp 163-164.  Proceedings, Thomas Addison and His Diseases: 200 Years International Symposium held in Padua, May 1993, J Endocrinology Ltd, Bristol, UK.
  425. New MI:  Apparent mineralocorticoid excess: A personal history.  In:  W Rosner, RB Hochberg, (eds),  Proceedings, First Symposium on 11b-hydroxysteroid-dehydrogenase, Kulturzentrum Appenberg, Bern, June 1993, Steroids 59: 66-68, 1994.
  426. New MI, Crawford C, Cheng KC, Wilson R:  Inborn errors of steroidogenesis.  In:  Ares Serono International Symposium on Cell and Molecular Biology of the Testis, held in Majorca Spain, Sept 1993,  In:  ML Dufau, A Fabbri, A Isidori (Eds), Ares-Serona Symposia Series-Frontiers in Endocrinology, vol 5, Rome, 1994, pp 27-38.
  427. Speiser PW, White PC, Dupont J, Zhu D, Mercado A, New MI:  Molecular genetic prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization.  Rec Prog Horm Res 49: 367-371, 1994.
  428. Speiser PW, White PC, Dupont J, Zhu D, Mercado A,  New MI:  Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot. Human Gen 93: 424-428, 1994.
  429. Speiser PW, New MI:  Hormonal hypertension in childhood.  In: N Lavin (ed), Manual of Endocrinology and Metabolism, Little Brown and Co, Boston, pp 161-173, 1994.
  430. New, M.I.:  Management of pain in hospitalized children.  In:  F Angelini (ed), Proceedings, Eighth International Conference, Puer natus est nobis: The Child is the Future of Society, Vatican City, November 1993; Trattamento del dolore nei bambini ospedalizzati.  Dolentium Hominum, 9: 274-275, 1994.
  431. New MI:  Congenital adrenal hyperplasia.  In: Proceedings, International Symposium on: Molecular Basis of Endocrine Diseases, Barcelona, November, 1993, In: Frontiers in Endocrinology, Vol 7, Serono Symposia Publication, Rome 1994, pp 55-73.
  432. Huma Z, Crawford C, New MI:  Congenital adrenal hyperplasia.  In:  CJD Brook (ed), Clinical Paediatric Endocrinology, 3rd edition, Chap 30, Blackwell Scientific, London, 1995 pp 536-557.
  433. Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD, Russell DW:  Natural mutagenesis study of the human steroid 5a-reductase 2 isozyme.  Biochemistry 33: 1265-1270, 1994.
  434. Qin K-N, New MI, Cheng K-C:  Molecular cloning of multiple cDNAS encoding human enzymes structurally related to 3a-hydroxysteroid dehydrogenase. J Steroid Biochem Molec Biol 46: 673-679, 1994.
  435. Speiser PW, New MI:  Prenatal diagnosis and management of congenital adrenal hyperplasia.  In: G Koren, S Ito (eds), Fetal Drug Therapy.  In:  S Hitchens (ed), Clinics in Perinatology, WB Saunders Co, Philadelphia, 1994 pp 631-645.
  436. New MI, Mercado AB, Wilson RC:  Prenatal hormonal therapy correcting genital ambiguity in adrenal steroid 21-hydroxylase deficient genetic females.  Proceedings, 1st Asian-Pacific Regional Meeting of International Society for Neonatal Screening, June 21-23, 1993, Sapporo.  In: N Takasugi and H Naruse (eds).  New Trends in Neonatal Screening, Hokkaido Univ. Press, Sapporo, 1994, pp 111-116.
  437. Bichet DG, Birnbaumer M, Lonergan M, Arthus M-F, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New MI, DiBona FJ, Kaplan BS, Robertson Gl, Hendy, GN, Fujiwara TM, Morgan K:  Nature and recurrence of AVPR2 mutations in x-linked nephrogenic diabetes insipidus.  Am J Human Gen  55:278-286, 1994.
  438. New MI, Ghizzoni L, Speiser PW:  Update on congenital adrenal hyperplasia.  In: F Lifshitz (ed), Pediatric Endocrinology, chapter 16, 3rd Ed, Marcel Dekker, New York, 1995, pp 305-320.
  439. New MI, Crawford C, Virdis R:  Low-renin hypertension in childhood.  In: F Lifshitz (ed), Pediatric Endocrinology, chapter 53, 3rd Ed, Marcel Dekker, New York, 1995, pp 775-789.
  440. Loche S, New MI:  Adrenal hyperplasia.  In: GP Redmond (ed), Androgenic Disorders, Raven Press, New York, 1995, pp 191-212. 
  441. Speiser PW, New MI:  Prenatal diagnosis and treatment of congenital adrenal hyperplasia.  J Ped Endocrinol 7:183-191, 1994.
  442. White PC, Tusie-Luna MT, New MI, Speiser PW: Mutations in steroid 21-hydroxylase (CYP21).  Human Mutation 3:373-378, 1994.
  443. New MI: The prismatic case of apparent mineralocorticoid excess.  J Clin Endocrinol Metab 79:1-3, 1994.
  444. Mercado AB, Wilson RC, Cheng KC, Wei J-Q, New MI:  Extensive personal experience:  Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.   J Clin Endocrinol Metab 80: 2014-2020, 1995.
  445. New MI:  Steroid 21-hydroxylase deficiency (Congenital adrenal hyperplasia).  Am J Med 98 (Suppl 1A), 1A1S-1A8S, 1995.
  446. New MI, Josso N:  Disorders of sexual differentiation, In:  J Claude Bennett, F Plum, Cecil Textbook of Medicine, 20th Edition, WB Saunders Co, Philadelphia, 1996, pp 1284-1293.
  447. New MI, C Crawford, RC Wilson:  Genetic disorders of the adrenal gland.  In:  DL Rimoin, JM Connor, RE Pyeritz (eds), Principles and Practice of Medical Genetics, 3rd Edition,  New York, Churchill, Livingstone, 1996, pp 1441-1476.
  448. New MI, White PC:  Genetic disorders of steroid hormone synthesis and metabolism.  In:  R Thakker (guest editor), Genetic and Molecular Biological Aspects of Endocrine Disease. In: KGMM Alberti, HG Burger, RD Cohen, MB Ranke (Series editors) Baillière's Clinical Endocrinology and Metabolism,  Baillière Tindall, London, 1995, pp 525-554.
  449. Trautman PD, Meyer-Bahlberg HFL, Postelnek J, New MI:  Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study.  Psychoendocrinology 20: 439-449, 1995.
  450. Zerah M, Rhéaume E, Mani P, Schram P, Simard J, Labrie F, New MI:  No evidence of mutations in the genes for type I and type II 3b-hydroxysteroid dehydrogenase (3bHSD) in nonclassical 3bHSD deficiency.  J Clin Endocrinol Metab 79: 1811-17, 1994.
  451. Wilson RC, Wei J-Q, Cheng KC, Mercado A, New MI:  Rapid deoxyribonucleic acid analysis by allele specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene.  J Clin Endocrinol Metab 80: 1635-1640, 1995.
  452. New MI, Mercado AB, Cheng KC, Jackowski M, Wilson RC:  Steroid 21-hydroxylase deficiency:  genotype may not predict phenotype.  In: MI New (ed), Where Phenotype Does Not Match Genotype, In: Frontiers in Endocrinology, Ares-Serono Symposia Series, vol. 16,  Rome, 1996, pp. 17-27.
  453. Pascoe L, Curnow KM, New MI, Corvol P:  The relationship between phenotype and genotype in glucocorticoid suppressible hyperaldosteronism (GSH).  In: MI New (ed), Where Phenotype Does Not Match Genotype, In: Frontiers in Endocrinology, Ares-Serono Symposia Series, vol. 16,  Rome, 1996, pp. 69-79.
  454. Simard J, Rhéaume E, Sanchez R, Mebarki F, Morel Y, Zerah M, New MI, Labrie F: Relation between molecular defect and phenotypic manifestation of human 3b-hydroxysteroid dehydrogenase deficiency.  In: MI New (ed), Where Phenotype Does Not Match Genotype, In: Frontiers in Endocrinology, Ares-Serono Symposia Series, vol. 16,  Rome, 1996, pp. 39-68.
  455. New MI, Rapaport R: The adrenal cortex, In: MA Sperling (ed), Pediatric Endocrinology, Chap. 12, WB Saunders, Philadelphia, 1996, pp 281-314.
  456. Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriguez A, Gertner J, New M, Hilgartner M:  Abnormal bone metabolism in thalassemia.  In:  S Andò et al. (eds), Endocrine Disorders in Thalassemia, Springer-Verlag, Heidelberg, 1995, pp 39-46.
  457. Wilson RC, Mercado AB, Cheng KC, New MI:  Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.  J Clin Endocrinol Metab 80: 2322-2329, 1995.
  458. New MI: Congenital adrenal hyperplasia, In: A Isidori, MI New, CP Sesma (eds),  Molecular Basis of Endocrine Diseases, Intl Symposium, Rome, November 18-19, 1993, In: Ares-Serona Symposia Series-Frontiers in Endocrinology, vol 7, 1994, pp. 55-74.
  459. New MI, Newfield RS:  Congenital adrenal hyperplasia.  In: CW Bardin (ed), Current Therapy in Endocrinology and Metabolism 6th edition, Mosby-Year Book, Phila, 1997, pp. 179-187.
  460. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CHL, Funder JW, New MI:  A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.  J Clin Endocrinol Metab 80: 2263-2266, 1995.
  461. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, Schwarz HP, Blethen SL, Mendonca BB, Bloise W, Witchel SF, Cutler GB Jr, Griffin JE, Wilson JD, Russell DW:  Molecular genetics and pathophysiology of 17b-hydroxysteroid dehydrogenase 3 deficiency.  J Clin Endocrinol Metab 81: 130-136, 1996.
  462. Speiser PW, Heier L, Serrat J, New MI, Nass R:  Failure of steroid replacement to consistently normalize pituitary function in congenital adrenal hyperplasia:  hormonal and MRI data.  Hormone Research 44: 241-246, 1995.
  463. New MI, Schram P:  Congenital adrenal hyperplasia.  In: RB Conn, WZ Borer, JW Snyder  (eds), Current Diagnosis 9, WB Saunders, Phila, 1997, pp 785-791.
  464. Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CH, Hanauske-Abel HM, Wei J-Q, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Licholai T, New MI:  Several homozygous mutations in the gene for 11b-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess.  J Clin Endocrinol Metab 80: 3145-3150, 1995. 
  465. Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW, Krozowski ZS:  The R337C mutation generates a high Km 11b-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess.  J Clin Endocrinol Metab  80: 3381-3383, 1995.
  466. New MI, Dluhy RG:  Steroid enzymatic abnormalities relating to hypertension. In:  M Sznajderman, W Januszewicz, A Januszewicz (eds), Hormonal Hypertension, Chap 8, Springer-Verlag, pp 205-247, 1997.
  467. New MI: Congenital Adrenal Hyperplasia.  Syllabus, Amer Assoc Clin Endocrinol 5th Ann Mtg, Seattle, May 1-5, 1996.  Annual Meeting, 1996.
  468. New MI: Infertility and androgen excess in nonclassical 21-hydroxylase deficiency.  Proceedings of Symposium on "The Ovary: Regulation, Dysfunction and Treatment", Florida January 25-27, 1996.  Excerpta Medica Intnl Congr Series 1106, pp 195-198, 1996.
  469. New MI:  Treatment-induced hypoandrogenism in childhood and puberty in females with virilizing (21-hydroxylase deficiency) CAH.  In: F Labrie, et al., (eds), Proc Intn Symp on DHEA Transformation into Androgens and Estrogens in Target Tissues: Intracrinology, Quebec, Sept 13-15, 1995.  J Endocrinology 150: S31-S32, 1996.
  470. Wajnrajch MP, New MI:  Disorders of the adrenal gland.  In: FD Burg, JR Ingelfinger, RA Polin, ER Wald (eds),  Current Pediatric Therapy 16, WB Saunders, Philadelphia, pp 744-753,  1998.
  471. Newfield RS, New MI:  21-Hydroxylase deficiency.  Proceedings of the Third International Congress Update on Adolescent Gynecology and Endocrinology, Dec 1995, Athens.  Ann NY Acad Sci 816: 219-229, 1997.
  472. NIH Technology Assessment Conference Panel - New MI (Panel Member): Gaucher disease.  JAMA 275: 548-553, 1996.
  473. Wilson RC, New MI:  Congenital adrenal hyperplasia.  In:  JL Jameson (ed), Textbook of Molecular Medicine, Blackwell Publishing, 1998.
  474. Ferrari P, Obeyesekere VR, Li K, Wilson RC, New MI, Funder JW, Krozowski ZS:  Point mutations abolish 11b-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excess.  J Mol Cell Endocrinol 119: 21-24, 1996.
  475. Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, El-Rashid R, New MI:  Dehydroepiandrosterone in morbidly obese adolescents:  effects on weight, body composition, lipids, and insulin resistance.  Metabolism 45: 1011-1015, 1996. 
  476. VanWyk JJ, Gunther DF, Ritzen M, Wedell A, Cutler GB, Migeon CJ, New MI:  The use of adrenalectomy as a treatment for congenital adrenal hyperplasia.  J Clin Endocrinol Metab 81: 3180-3182, 1996.
  477. Miller WL, New MI:  Genetics of adrenal steroid disorders.  In:  J Baxter, S Melmed, MI New     (eds), Genetics in Endocrinology,  In: L Martini (Ed-in-chief), Modern Endocrinology, Lippincott-Raven, Philadelphia, 2002, p. 331.
  478. New MI:  Endocrine and molecular basis of 21-hydroxylase deficiency congenital adrenal hyperplasia in Ashkenazim.  In:  RJ Desnick (ed), Advances in Jewish Genetic Diseases, Oxford University Press, London, 1997.
  479. Meyer-Bahlburg HFL, Gruen RS, New MI, Bell JJ, Morishima A, Shimshi M, Bueno Y, Vargas I, Baker SW: Gender change from female to male in classical congenital adrenal hyperplasia.  Hormones and Behavior 30: 319-332, 1996.
  480. Dumic M, Brkljacic L, Plavsic V, Zunec R, Ille J, Wilson RC, Kuvacic I, Kastelan A, New MI:  Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia.  Amer J Med Gen 302-306, 1997.
  481. Burstein S, Crawford C, New MI, Loche S:  Congenital adrenal hyperplasia: female pseudohermaphroditism and virilization.  In:  JJ Sciarra (ed), Gynecology and Obstetrics, Vol 5, Chap 78, Lippincott-Raven, Philadelphia, 1997, 1-22.
  482. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG:  Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remedial aldosteronism.  J Clin Endocrinol Metab 82: 3570-3573, 1997.
  483. New MI:  Diagnosis and management of congenital adrenal hyperplasia.  Ann Rev Med 49: 311-28, 1998.
  484. New MI:  Biosynthetic disorders:  congenital adrenal hyperplasia.  In: A Pinchera (ed), Endocrinology and Metabolism.  pp. 305-310, 2001.
  485. Nass R, Heier L, Moshang T, Oberfield S, Ajax G, New MI, Speiser PW:  Magnetic resonance imaging in the congenital adrenal hyperplasia population:  increased frequency of white-matter abnormalities and temporal lobe atrophy.  J Child Neurol 12: 181-186, 1997.
  486. Trautman PD, Meyer-Bahlburg HF, Postelnek J, New MI:  Mother's reactions to prenatal diagnostic procedures and dexamethasone treatment of congenital adrenal hyperplasia.  J Psychosom Obstet Gynaecol 17: 175-81, 1996. 
  487. New MI:  Congenital adrenal hyperplasia: 21-hydroxylase deficiency.  In: AN Margioris and GP Chrousos (eds) Adrenal Disorders, Humana Press, New Jersey. Pp. 263-271. 1999.
  488. New MI:  Inborn errors of steroidogenesis.  In:  Proceedings of the XVIII Mtg Intnl Study Group for Steroid Hormones, Rome, Italy, Nov. 1998, JW Funder (guest editor), In: Steroids 63: 238-242, 1998.
  489. Zhang Y-H, Guo W, Wagner RL, Huang B-L, McCabe L, Vilain E, Burris TP, Anyane-Yeboa K, Burghes AHM, Chitayat D, Chudley AE, Genel M, Gertner JM, Klingensmith GJ, Levine SN, Nakamoto J, New MI, Pagon RA, Pappas JG, Quigley CA, Rosenthal IM, Baxter JD, Fletterick RJ, McCabe ERB:  DAX1 mutations map to putative structural domains in a deduced three-dimensional model.  Am J Hum Gen 62: 855-864, 1998.
  490. Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Razzaghy-Azar, Krozowski ZS, Funder JW, Shackleton CHL, Bradlow HL, Wei J-Q, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Akkurt HI, DeSantis C, New MI:  Extensive personal experience:  examination of genotype and phenotype relationships in 14 patients with apparent-mineralocorticoid excess.  J Clin Endocrinol Metab 83: 2244-2254, 1998.
  491. Querica N, Chitayat D, Babul-Hirji R, New MI, Daneman D: Normal external genitalia in a female with classical congenital adrenal hyperplasia who was not treated during embryogenesis.  Prenatal Diagnosis  18: 83-85, 1998.
  492. Vogiatzi MG, New MI:  Differential diagnosis and therapeutic options for ambiguous genitalia.  Cur Op Endocr Diab 5: 3-10, 1998.
  493. Wilson RC, Dave-Sharma S, Wei J-Q, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CHL, Bradlow L, Wiens T, New MI:  A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci USA 95: 10200-10205, 1998.
  494. Carlson AD, Obeid JS, Kanellopoulou, Wilson RC, New MI:  Congenital adrenal hyperplasia:  update on prenatal diagnosis and treatment.  In:  F Labrie (ed), Proceedings of the Xth International Congress on Hormonal Steroids, Quebec, June 17-21, 1998. In: J Steroid Biochem Mol Biol  69:19-29, 1999.
  495. Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.  In:  MI New (ed), Diagnosis and Treatment of the Unborn Child, Idelson-Gnocchi Ltd, Reddick, 1999, pp 74-84.
  496. Nimkarn S, Cerame BI, Wei J-Q, Dumic M, Zunec R, Brkljacic L, Skrabic V, New MI, Wilson RC: Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.  J Clin Endocrinol Metab 84: 378-381, 1999.
  497. New MI, Nimkarn S, Brandon S, Cunningham-Rundles S, Wilson RC, Newfield RS, Vandermeulen J, Barron N, Russo C, Loriaux DL, O’Malley B:  Resistance to several steroids in two sisters.  J Clin Endocrinol Metab 84: 4454-4464, 1999.
  498. Damore ME, Speiser PW, Slonim AE, New MI, Shanske S, Xia W, Santorelli FM, DiMauro S: Early onset of diabetes mellitus associated with the mitochondrial DNA T14709C point mutation: patient report and literature review.  J Ped Endocrinol Metab 12: 207-213, 1999.
  499. Cerame BI, Newfield RS, Pascoe L, Curnow KM, Nimkarn S, Roe TF, New MI, Wilson RC: Prenatal diagnosis and treatment of 11b-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.  J Clin Endocrinol Metab 84: 3129-3134, 1999.
  500. Newfield RS, Kalaitzoglou G, Licholai T, Chilton D, Ashraf J, Thompson EB, New MI.  Normocortisolemic Cushing’s syndrome initially presenting with increased glucocorticoid receptor numbers.  J Clin Endocrinol Metab 85;14-21, 2000.
  501. New MI, Wilson RC.  Inaugural Article: Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.   Proc Natl Acad Sci  96:12790-12797, 1999.
  502. Ugrasbul F, Wiens T, Rubinstein P, New MI, Wilson RC.  Prevalence of mild apparent mineralocorticoid excess in Mennonites.  J Clin Endocrinol Metab  84: 4735-4738, 1999.
  503. New MI, Obeid J, Wilson RC, Cabrera MS, Goseco A, Macapagal MC, Marshall I, Nimkarn S, Quintos JB, Ten S, Ugrasbul F, Vandermolen L, Harbison MD.  Profile of the Pediatric Endocrine Clinic at New York-Presbyterian Hospital, New York Weill Cornell Center.  J Clin Endocrinol Metab 84: 4444-4449, 1999.
  504. Spiro RP, Christian SL, Ledbetter DH, New MI, Wilson RC, Roizen N, Rosenfield RL.  Intrauterine growth retardation associated with maternal uniparental disomy for chromosome 6 unmasked by congenital adrenal hyperplasia.  Ped Res  46:510-13, 1999.
  505. New MI, Josso N:  Disorders of sexual differentiation.  In:  L Goldman, J Claude Bennett (eds), Cecil Textbook of Medicine, 21st Edition, WB Saunders Co, Philadelphia, pp 1297-1306, 1999.
  506. Newfield RS, Spitz IM, Isacson C, New MI:  Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia.  Clin Endocrinol 54(3):399-404, 2001.
  507. Wajnrajch JP, New MI:  Defects of adrenal steroidogenesis.  In:  LJ DeGroot, JL Jameson (eds), Endocrinology, 4th edition, W.B. Saunders Co, Philadelphia, pp 1721—1739, 2001.
  508. Cerame BI, New MI:  Hormonal hypertension in children:  11b-hydroxylase deficiency and apparent mineralocorticoid excess.  J Ped Endocrinol Metab  13(9): 1537-1547, 2000.
  509. New, MI:  Congenital adrenal hyperplasia:  21-hydroxylase deficiency and 11b-hydroxylase deficiency.  In:  E Darracott Vaughan, Jr. (eds), Renal and Adrenal Tumors – Biology and Management, Oxford University Press.  Ch. 54. (752 pgs.), 2003.
  510. Speiser PW, New MI:  Hormonal hypertension in childhood.  In: N Lavin (ed), Manual of Endocrinology and Metabolism, 3rd edition, Lippincott Williams & Wilkins. Pp. 163-179, 2002.
  511. New MI:  Antenatal diagnosis and treatment.  Current Urology Reports  2(1):11-18, 2001.
  512. Wilson RC, Nimkarn S, New MI:  Apparent mineralocorticoid excess.  Trends in Endocrinology and Metabolism 12(3):104-111, 2001.
  513. New, MI: Prenatal Treatment of CAH:  US Experience. Endocrinology and Metabolism Clinics of North America   Ed., PW Speiser, 20(1): 1-14, 2001.
  514. New, MI, Ghizzoni L: An update on congenital adrenal hyperplasia.  Ed., F Lifshitz.  Pediatric Endocrinology, 3rd Ed., Marcel Dekker, New York. Pgs. 305-320. 1999.  4th Ed. Pp. 175-192, 2003. 
  515. Fisch H, Golden RJ, Libersen GL, Hyun GS, New MI, Hensle TW. Hypospadias incidence rates and associated risks with advancing maternal age.  J Urol, 165(3):934-936. 2001.
  516. Wajnrajch M, New MI:  Disorders of the adrenal gland:  vomiting in a 3-week-old boy.  In:  Fredric D. Burg, Victor C Vaughan III, Kathleen G. Nelson (eds), Review of Pediatrics, Chap. 43, pp 105-109, 2001.
  517. New MI, Wilson RC:  Genetic disorders of the adrenal gland.  In:  DL Rimoin, Emery (eds), Emery & Rimoin’s Principles and Practice of Medical Genetics, 4th  Edition, Churchill, Livingstone, 5: pp. 2277-2314, 2002.
  518. New MI, Carlson A, Obeid J, Marshall I, Goseco A, Cabrera M, Lin-Su K, Putnam AS,  Wei JQ, Wilson RC. Extensive Personal Experience: Prenatal Diagnosis for Congenital Adrenal Hyperplasia in 532 Pregnancies. J Clin Endocrinol Metab , 86 (12):5651-5657, 2001.
  519. New MI: Female pseudohermaphrodism and CAH. Ed., JM Fauser Reproductive Medicine: Molecular, Cellular and Genetic Fundamentals, 2nd Edition, Parthenon.  Pgs. 565-574, 2003.
  520. Quintos JBQ, Vogiatzi MG, Harbison MD, New MI: Growth hormone therapy alone or in combination with GnRH analogue therapy to improve the height deficit in children with CAH. J Clin Endocrin Metab, 86(4):1511-1517,  2001.
  521. Meyer-Bahlburg HFL, Gidwani S, Dittmann RW, Dolezal C, Baker SW, Morishima A, Bell JJ, New MI. Psychosexual Quality of life in adult intersexuality: The example of congenital adrenal hyperplasia. B Stabler, BB Bercu (eds) 1997 Symposium on Therapeutic Outcome of Endocrine Disorders, Springer, New York, 2000.
  522. Cabrera M, Vogiatzi M, New MI. Long term outcome in adult males with congenital adrenal hyperplasia. J Clin Endocrin Metab, 86(7):3070-3078, 2001.
  523. Wajnrajch, M, Gertner JM, Huma Z, Popovic J, Lin K, Verlander PC, Batish SD, Giampietro PF, Davis JG, New MI, Auerbach AD. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics, 107(4):744-754, 2001.
  524. New MI. Letter to the Editor: Prenatal treatment of congenital adrenal hyperplasia-author differs with technical report. Pediatrics, 107(4):804, 2001.
  525. Ten S, New MI, Maclaren N. Clinical review of Addison’s disease. J Clin Endocrinol Metab, 86(7):2909-2922, 2001. 
  526. Gmyrek GA, New MI, Sosa RE, Poppas DP. Bilateral laparoscopic adrenalectomy as a           treatment for classic congenital adrenal hyperplasia attributable to 21-hyroxlyase deficiency. Pediatrics, 109 (2):28, 2002.
  527. Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP. Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. JCEM 87(7):3031-3037, 2002.
  528. Marshall I, New MI. Genetic basis of mineralocorticoid disorders. Encyclopedia of Hormones & Related Cell Regulators. Henry HL, Norman AW (eds.) Academic Press, San Diego. Vol 2. pp.679-685, 2003.
  529. Marshall I, New MI.  Endocrine Hypertension of Childhood.  In: DeGroot, L. www.endotext.org: your Endocrine Source: Pediatric Endocrinology, 2002. 
  530. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wilson RC.  Update: prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies. In: New MI (ed) Hormonal and Genetic Basis of Sexual Differentiation Disorders, Tempe, Az. The Endocrinologist, pp. 233-239, 2003.
  531. New MI.  Prevention of ambiguous genitalia by prenatal treatment with dexamethasone in pregnancies at risk for congenital adrenal hyperplasia.  Pure and Applied Chem.  75(11-12):2013-2022, 2003.
  532. Marshall I, New MI.  Adrenal disorders.  In: DeGroot L (ed) www.endotext.org: your Endocrine Source: Pediatric Endocrinology, 2002. 
  533. New MI.  Inborn errors of steroidogenesis.  Proceedings of the First International Workshop on Anti-Mullerian hormone/Mullerian Inhibiting Substance, Aix-en-Provence, France.  Molecular and Cellular Endocrinology. 211(1-2): 75-84, 2003. 
  534. Dumic M, Ille J, Zunec R, Plavsic V, Francetic I, Skrabic V, Janjanin N, Spehar A, Wei JQ, Wilson RC, New MI.  Nonclassic 21-Hydroxylase Deficiency in Croatia.  J Pediatr Endocrinol Metab.  17:157-164, 2004.
  535. New MI.  Sex hormone disorders: congenital adrenal hyperplasia.  In: Encyclopedia of Life Sciences.  Macmillan Publishers Ltd. 2003.
  536. New MI.  21-Hydroxylase deficiency: classical and nonclassical congenital adrenal hyperplasia. In: DeGroot L (ed) www.endotext.org: your Endocrine Source: Pediatric Endocrinology, 2003. 
  537. New MI. Hypertension in Congenital Adrenal Hyperplasia and Apparent Mineralocorticoid Excess. Ann. N.Y. Acad. Sci. 970: 145-154, 2002.
  538. Marshall I, Ugrasbul, Manginello F, Wajnrajch MP, Shackleton CHL, New MI, Vogiatzi MV.  Congenital hypopituitarism as a cause of undetectable estriol levels in the maternal triple-marker screen.  J Clin Endocrinol Metab.  88: 4144-8, 2003.
  539. Tukel T, Uyguner O, Wei JQ, Yuksel-Apak M, Bas F, Song DX, Kayserili H, Saka N, Gunoz H, Wilson RC, New MI, Wollnik B.  A Novel Semi-Quantitative PCR / Enzyme Digestion Based Method For Detection Of Large Scale Deletions/Conversions Of The CYP21A2 Gene And Mutation Screening In Turkish Families With 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 88: 5893-5897, 2003.
  540. Lin-Su K, Betensky BP, Vogiatzi MV, New MI.  Is there a case for growth hormone treatment in congenital adrenal hyperplasia? Int Growth Monit. 13(3): 2-5, 2003.
  541. Wilson RC, New MI.  Congenital adrenal hyperplasia.  In:  JL Jameson (ed), Principles of Molecular Medicine. Totowa: Humana Press, pp 481-493, 1998.
  542. Chemaitilly W, Wilson RC, New MI.  Hypertension and Adrenal Disorders.  Current Hypertension Reports.  5(6):498-504, 2003.
  543. Karen Lin-Su, Ping Zhou, Nimmi Arora, Brian P Betensky, Maria I. New and Robert C. Wilson.  In Vitro Expression Studies Of A Novel Mutation Δ299 In A Patient Affected With Apparent Mineralocorticoid Excess (AME).  J Clin Endocrinol Metab. 89:2024-27, 2004.
  544. Chemaitilly W, Betensky BP, Marshal I, Wei JQ, Wilson RC, New MI.  Case report: the natural history and genotype-phenotype nonconcordance of HLA identical siblings with the same mutations of the 21-hydroxylase gene.  J Peds Endocrinol Metab.  18:143-54, 2005.
  545. Motaghedi R, Betensky BP, Slowinska B, Cerame B, Cabrera M, New MI, Wilson RC.  Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 11b-hydroxylase deficiency.  J Peds Endocrinol Metab.  18:133-42, 2005.
  546. Meyer-Bahlburg HFL, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.  J Clin Endocrinol Metab.  89(2):610-614, 2004.
  547. Meyer-Bahlburg HFL, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI. Prenatal Androgenization Affects Gender-Related Behavior But Not Gender Identity in 5–12-Year-Old Girls With Congenital Adrenal Hyperplasia. Arch Sex Behav.  33(2):97-104, 2004.
  548. New MI, Betensky BP.  21-hydroxylase deficiency.  In: Pagon, RA (ed.): GeneTests: www.genetests.org, 2004.
  549. Wajnrajch M and New MI:  Congenital adrenal hyperplasia.  In:  LJ DeGroot and JL Jameson (eds), Endocrinology, 5th edition, W.B. Saunders Co: Philadelphia, 2005.
  550. Keen-Kim D, Redman JB, Alanes RU, Eachus MM, Wilson RC, New MI,. Nakamoto JM, Fenwick RG.  Validation and Clinical Application of a Locus-Specific PCR- and Minisequencing-Based Assay for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency).  Journal of Molecular Diagnostics.  7(2):236-46, 2005. 
  551. New MI, Geller DS, Fallo F, Wilson RC.  Monogenic low renin hypertension.  Trends in Endocrinology and Metabolism.  16(3):92-7, 2005.
  552. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI.  Treatment with Growth Hormone and LHRH Analogue Improves Final Adult Height in Children with Congenital Adrenal Hyperplasia.  J Clin Endocrinol Metab.  90: 3318 – 3325, 2005. 
  553. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M.  Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.  J Hypertens. 23: 1477-1484, 2005. 
  554. New, Maria I. Puberty Problems Updated. Trends in Endocrinology and Metabolism. 16(10): 444, 2005.
  555. New, M I. An Update of Congenital Adrenal Hyperplasia. Ann N Y Acad Sci. 1038: 14-43, 2004.
  556. Dumic M, Janjanin N, Ille J, Zunec R, Spehar A, Zlopasa G, Francetic I, New MI. Pregnancy Outcomes in Women with Classical Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.  J Pediatr Endocrinol Metab.  18(9):887-95, 2005.
  557. Ergun-Longmire B, Vinci G, Alonso L, Tansil S, Lin-Su K, McElreavey K, New MI.  Clinical, hormonal and cytogenetic evaluation of 46,XX males and review of the literature.  J Pediatr Endocrinol Metab.  23(8):739-48, 2005.
  558. New MI, Ghizzoni L, Lin-Su K. Chapter 9: An Update of Congenital Adrenal Hyperplasia.  In: F Lifshitz (ed), Pediatric Endocrinology, 5th Edition.  Marcel Dekker: New York. p228-245, 2007
  559. New, MI. Nonclassical 21-hydroxylase deficiency.  In: Proceedings of the 3rd Special Scientific Meeting of the Androgen Excess Society; 2005 Sep 30 – Oct 1; Ravello, Italy. Fertil Steril. 86 Suppl 1:S2, 2006.
  560. New MI, Wilson RC.  Genetic disorders of the adrenal gland.  In:  DL Rimoin, Emery (eds), Emery & Rimoin’s Principles and Practice of Medical Genetics, 5th Edition.  London: Churchill Livingstone. p.2023-2054, 2006.
  561. Ergun-Longmire B, Auchus R, Papari-Zareei M, Tansil S, Wilson RC, New MI.  Two novel mutations found in a patient with 17α-hydroxylase deficiency.  J Clin Endocrinol Metab 91(10):4179-82, 2006.
  562. Nimkarn S, New MI.  Prenatal diagnosis and treatment of congenital adrenal hyperplasia.  Nature Clinical Practice Endocrinology and Metabolism. 3(5):405-413, 2007
  563. Nimkarn S, New MI.  Prenatal diagnosis and treatment of congenital adrenal hyperplasia.  Horm Res 67:53-60, 2007.
  564. Nimkarn S, New MI.  Prenatal diagnosis and treatment of congenital adrenal hyperplasia.  Pediatric Endocrinology Reviews. 4(2) 99-105, 2006
  565. New, MI.  Extensive Clinical Experience: Nonclassical 21-Hydroxylase Deficiency.  J Clin Endo Metab 91:4222-4231, 2006.
  566. New MI, Nimkarn S. 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia (Updated September 2006). In: GeneReviews at GeneTests: Medical Genetics Information Resource (online database). Copyright: University of Washington, Seattle, 1997-2006. Available at www.genetests.org.
  567. New MI. 21-hydroxylase deficiency. In: Genetics Home Reference, http://ghr.nlm.nih.gov. Update July 2006.
  568. Wilson RC, New MI.  Congenital adrenal hyperplasia.  In:  JL Jameson (ed), Principles of Molecular Medicine, 2nd ed. Totowa: Humana Press, 2006. p365-376.
  569. New MI, Nimkarn S. Review of “Apparent Mineralocorticoid Excess Manifested in an Elderly Patient with Hypothyroidism” by Inagaki et al. Am J Hypertens. 20(1):108, 2007.
  570. Nimkarn S, Lin-Su K, Berglind N, Wilson R, New MI.  Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Congenital Adrenal Hyperplasia. J Clin Endo Metab. 92(1):137-42, 2007.
  571. Meyer-Bahlburg HF, Dolezal C, Baker SW, Ehrhardt AA, New MI. Gender Development in Women with Congenital Adrenal Hyperplasia as a Function of Disorder Severity. Arch Sex Behav. 35:667-684, 2006.
  572. Bhangoo A, Wilson R, New MI, Ten S. Donor splice mutation in the 11β-hydroxylase (CYP11B1) gene resulting in sex reversal: a case report and review of the literature. J Pediatr Endocrinol Metab. 19:1267-1282, 2006.
  573. New MI. Congenital Adrenal Hyperplasia and Poverty. J Ped Endocrinol Metab. 19:1191, 2006.
  574. Chalmers LJ, Casas L, New MI, Blackett PR.  Prolongation of growth by treatment of 11-hydroxylase deficiency with depot-leuprolide, growth hormone and hydrocortisone. J Pediatr Endocrinol Metab. 19:1251-1255, 2006.
  575. Diaz A, New MI. Aldosterone. In: McGraw-Hill Encyclopedia of Science and Technology, 10th ed. New York: McGraw-Hill. p423-424, 2007.
  576. Meyer-Bahlburg HFL, Dolezal C, Zucker KJ, Kessler SJ, Schober JM, New MI.  The Recalled Gender Questionnaire-Revised: A Psychometric Analysis in a Sample of Women with Congenital Adrenal Hyperplasia.  J Sex Res. 43(4):364-367, 2006.
  577. Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar M, Najmabadi H, Saffari F, New MI.  Ethnic Specific Distribution of Mutations in 716 Patients with Congenital Adrenal Hyperplasia Owing to 21-Hydroxylase Deficiency. Mol Genet Metab. 90(4):414-21, 2007.
  578. Trinh L, Nimkarn S, New MI, Lin-Su K. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  J Ped Endocrinol Metab.  20:883-891, 2007.
  579. New, MI. Prismatic Case: “Apparent Mineralocorticoid Excess Manifested in an Elderly Patient with Hypothyroidism.” Mt Sinai J Med. 74:40-10, 2007
  580. Lin-Su K, New MI.  “Effect of Adrenal Steroids on the Bone Metabolism of Children with Congenital Adrenal Hyperplasia.” Ann NY Acad Sci. 1117: 345-351, 2007.
  581. Dumic M, Lin-Su K, Leibel N, Ciglar S, Vinci G, Lasan R, Nimkarn S, Wilson JD, McElreavey K, and New MI. “Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development.” J Clin Endo Metab 93 (1): 182-189, 2008.
  582. James N, Speiser PW, New MI:  Congenital Adrenal Hyperplasia.  In: N Lavin (ed), Manual of Endocrinology and Metabolism. Lipincott, Williams and Wilkins. 2009.
  583. Meyer-Bahlburg HFL, Dolezal C, Baker S, New MI. “Sexual Orientation in Women with Classical or Non-classical Congenital Adrenal Hyperplasia as a Function of Degree of Prenatal Androgen Excess.” Arch Sex Behav. 37(1):85-99, 2008.
  584. Lin-Su K, New MI. “Inactivation of the Acid Labile Subunit Gene Resulting in Insulin-Like Growth Factor Deficiency: Review of a Prismatic Case.” Mt Sinai J Med. 75:000-000, 2008.
  585. Nimkarn S, New MI. “Steroid 11B-hydroxylase Deficiency Congenital Adrenal Hyperplasia.” Trends in Endocrinology and Metabolism.  19(3):96-99, 2008.Lin-Su K, Nimkarn S, and New MI. “Diagnosis and Management of Congenital Adrenal Hyperplasia in Adolescents.” Ann NY Acad Sci. 1193: 95-98, 2008.
  586. Nimkarn S, Lin-Su K, Kaltman J, and New MI.  “Congenital Adrenal Hyperplasia.” British Medical Journal.  July 2008
  587. Lin-Su K, Nimkarn S, and New MI.  “Treatment and Management of Congenital Adrenal Hyperplasia in Adults.”  Expert Review of Endocrinology and Metabolism. Expert Review of Endocrinology & Metabolism, January 2009, Vol. 4, No. 1, Pages 67-77
  588. Funder J, New MI. “Low renin hypertension (LRH): shades of John Laragh.” Trends in Endocrinology and Metabolism. 19(3):83, 2008.
  589. Dumic M, Lin-Su K, Leibel N, Ciglar S, Vinci G, Lasan R, Nimkarn S, Wilson JD, McElreavey K, and New MI.. “Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development: Review of a Prismatic Case.” Mt Sinai J Med. 75: 168-169, 2008.
  590. Guevarra F, New MI. “Mutation of Growth Hormone Receptor in Children with Idiopathic Short Stature: Review of a Prismatic Case.” Mt Sinai J Med. 2008 Mar-Apr;75 (2):168-9.
  591. Bas F, Kayserili H, Darendeliler F, Uyguner O, Gunoz H, Yuksel-Apak M, Atalar F, Bundak R, Wilson RC, New MI, Wollnik B, Saka N. “CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype-phenotype correlation in Turkish children” J Clin Res Ped Endo,  2009 Feb; 1(3): 116-128.
  592. Nimkarn S, New MI. “Congenital Adrenal Hyperplasia.” In: RE Weiss, S Refetoff (eds), Genetic Diagnosis of Endocrine Disease, 1st Edition. San Diego: Elsevier. (In Press)
  593. Nimkarn S, New MI. “Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia” Mol Cell Endocrinol , Mar 5;300(1-2):192-6, 2009.
  594. Quintos JB, Krotz S, Vogiatzi MG, Kralickova M, New MI. “Partial Hypogonadotropic Hypogonadism Associated with the Leu266Arg and Gln106Arg Mutation of the Gonadotropin-Releasing Hormone Receptor.” Journal of Pediatric Endocrinology and Metabolism 2009 Feb;22(2):181-5.
  595. Guevarra FM, Nimkarn S, New MI, Lin-Su K. “Long-term Growth Hormone Therapy in an Adolescent Boy with 45,X/46,XidicY(p11): A Case Report and Review of the Literature.” Journal of Pediatrics. 2009 Nov;155(5):752-5.e1-3.
  596. Nimkarn S, New MI, “Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency; a Paradigm for Prenatal Diagnosis and Treatment.” Annals of the New York Academy of Sciences Issue: Skeletal Biology and Medicine. 2010, 1192, 5-11
  597. Nimkarn S, Lin-Su K, New MI. “Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia.” Endocrinol Metab Clin North Am. 2009 Dec;38(4):699-718.
  598. Donnelly MP, Peristera P, Grigorenko E, Gurwitz D, Mehdi SQ, Kajuna SLB, Barta C, Kungulilo S, Karoma NJ, Lu R, Zhukova OV, Kim J, Comas D, Siniscalco M, New MI, Li P, Li H, Manolopoulos VG, Speed WC, Rajeevan H, Pakstis AJ, Kidd JR, Kidd K. “The Distribution and Most Recent Common Ancestor of the 17q21 Inversion in Humans.” Am J Hum Genet. 2010 Feb;86:161-171.
  599. Dumic K, Wilson R, Thanasawt P, Grubic Z, Kusec V, Stingl K, New MI. “Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS+4A to G) in one CYP11B1 allele and R448H in exon 8 in the other.”  Eur J Pediatr. 2010 Jul;169(7):891-894.
  600. George MM, New MI, Ten S, Sultan C, Bhangoo A. “The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency.” Horm Res Paediatr. 2010 Aug;[epub].
  601. Parsa A, Lekarev O, New MI. “Disorders of Sexual Differentiation.” Clinical Genomics: Practical Applications in Adult Patient Care. 2010.
  602. Parsa A, Lekarev O, Lin-Su K, New MI. “Congential Adrenal Hyperplasia.” Clinical Genomics: Practical Applications in Adult Patient Care. 2010.
  603. Wajnrajch M, New MI. “Defects of Adrenal Steroidogenesis.” Endocrinology: Adult and Pediatric. 2010;6:1899-1916.
  604. Meyer-Bahlburg HFL, Dolezal C, Kassai B, Chatelain P, Forest MG, New MI. Dexamethasone treatment of pregnancies at risk for Congenital Adrenal Hyperplasia diminishes behavioral masculinization/defeminization of offspring in adolescence and young adulthood (poster). European Society for Sexual Medicine, 13th Congress, Malaga, Spain, November 14-17, 2010.
  605. Keen-Kim D, Redman J, Alanes R, Eachus M, Wilson R, New M, Nakamoto J, Fenwick G. “Validation and Clinical Application of a Locus-Specific Polymerase Chain Reaction- and Minisequencing-Based Assay for Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency).” Journal of Molecular Diagnostics. 2005;7:236-246.
  606. Lekarev O, Parsa, A, Nimkarn S, Lin-Su K, New MI. Congenital Adrenal Hyperplasia. In: DeGroot, L. www.endotext.org: your Endocrine Source: Pediatric Endocrinology, 2010.
  607. Ghanny S, Philibert P, Nie L, Tan D, Predescu I, Bhandaria S, Chrousos G, Stratakis C, New MI, Michl J, Lacbawan F, Sultan C, Bhangoo A, Ten S. “Glucocorticoid Resistance as a Cause of Hyperandrogenism From Childhood to Adulthood” (Abstract). Endocrine Society Meeting, Boston, MA, June 4-7, 2011.
  608. New MI. “Description and defense of prenatal diagnosis and treatment with low-dose dexamethasone for congenital adrenal hyperplasia.” American Journal of Bioethics. 2010 Sep; 10(9): 48-51.
  609. New MI. “Vindication of prenatal diagnosis and treatment of congenital adrenal hyperplasia with low-dose dexamethasone.” American Journal of Bioethics. 2010 Dec; 10(12):67-8.
  610. New MI. Ancient History of Congenital Adrenal Hyperplasia. In: Ghizzoni L, Cappa M, Chrousos G, Loche S, Maghnie M (eds), Pediatric Adrenal Diseases, Endocr Dev. Basel: Karger. 2011: 202-211.
  611. Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG and New MI. “Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone.” J Clin Endo Metab. 2011 June; 96(6):1710-1717.
  612. Parsa AA, New MI. “Low-renin hypertension in childhood.” Encocrinol Metab Clin North Am. 2011 June; 40 (2): 369-377, vii.
  613. New MI, Parsa AA. “Long range outcome of prenatal treatment.” Adv Exp Med Biol. 2011; 707: 33-5.
  614. Harbison MD, Lin-Su K, New MI. “Growth hormone treatment in children with congenital adrenal hyperplasia.” Adv Exp Med Biol. 2011; 707: 107.
  615. Lekarev O, Morel Y, New MI. “Atypical presentation and novel StAR protein gene mutation in a 46, XY female with lipoid congenital adrenal hyperplasia.” Adv Exp Med Biol. 2011; 707: 133-4.
  616. Dumic M, New MI, Lin-Su K, McElreavey K, Leibel NI, Ciglar S, Nimkarn S, Vinci G, Wilson J, Lassan R. “Report of fertility in a women with a predominantly 46, XY karyotype in a family with multiple disorders of sexual development.” Adv Exp Med Biol. 2011; 707: 169-170.
  617. McEvoy MP, Rich BS, New M, Tang LH, La Quaglia MP. “Thymic carcinoid presenting with Cushing’s Syndrome in a 17-year-old boy: A case report and review of the literature.” J Clin Oncol. 2011; 29(25):e716-e718.
  618. New MI, Parsa A. “Long-range Outcome of Prenatal Treatment for CAH.” Hormonal and Genetic Basis of Sexual Differentiation Disorders and Hot Topic in Endocrinology: Proceedings of the 2nd World Conference. New MI, Simpson JL (eds). Springer 2011.
  619. New MI, Lekarev O, Adrenal Emergencies, in Android and iPhone APP, “Endocrinology and Endocrine Emergencies”, Leslie J De Groot MD Editor, published October 2011 by Endocrine Education Inc., South Dartmouth, MA, USA
  620. Rabbani B, Mahdieh N, Ashtiani MT, Larijani B, Akbari MT, New MI, Parsa A, Schouten JP, Rabbani A. “Mutation Analysis of CYP21A2 Gene in Iranian Population.” Genet Test Mol Biomarkers. 2011, Oct 21. Epub.
  621. Hann M, Kshetrapal A, New MI, Simpson JL. “Novel Therapies for Treating Short Stature with Congenital Adrenal Hyperplasia.” International Journal of Infertility and Fetal Medicine. 2011; 2: 45-50.
  622. Nimkarn S, Lin-Su K, New MI. “Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia.” Pediatr Clin North Am. 2011 Oct; 58(5):1281-300.
  623. George MM, Sinha S, Mamkin I, Philibert P, New MI, Wilson RC, Sultan C, Ten S, Bhangoo A. “Isolated mild clitoral hypertrophy may reveal 46,XY disorders of sex development in infancy due to 17-beta-HSD-3 defect confirmed by molecular analysis.” Gynecol Endocrinol. 2011 Nov;27(11):890-4.
  624. Lekarev O, New MI. “Adrenal Disease in Pregnancy.” Best Practice and Research Clinical Endocrinology and Metabolism. 25 (2011): 959-973.
  625. Lekarev O, Mallet D, Yuen T, Morell Y, New MI. “Congenital lipoid adrenal hyperplasia (a rare form of adrenal insufficiency and ambiguous genitalia) caused by a novel mutation of the steroidogenic acute regulatory protein gene.” Eur J Pediatr. Nov 2011: Epub.
  626. New MI, Abraham M, Yuen T, Lekarev O. “An Update on Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia.” Semin Reprod Med. 2012 Oct;30(5): 396-9
  627. Meyer-Bahlburg HFL, Dolezal C, Haggerty R, Silverman M, New MI. “Cognitive Outcome of Offspring from Dexamethasone-Treated Pregnancies at Risk for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency” European Journal of Endocrinology.  2012. 167 (1): 103-10
  628. New MI, Lekarev O, Yuen T, Lo DYM. “Non-invasive prenatal diagnosis of congenital adrenal hyperplasia.” [Abstract]. 11th International Conference on Preimplantation Genetic Diagnosis. May 17-19, 2012.
  629. Lekarev O, Parsa, New MI. Congenital Adrenal Hyperplasia: Diagnosis and Emergency Treatment. In: DeGroot, L. www.endotext.org: your Endocrine Source: Pediatric Endocrinology, 2012. 
  630. Zhu LL, Blair H, Cao J, Yuen T, Latif R, Guo L, Tourkova IL, Li J, Davies TF, Sun L, Bian Z, Rosen C, Zallone A, New MI, Zaidi M. “Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.” PNAS. 2012 Sep 4;109(36):14574-9.
  631. Lekarev O, Tafuri K, Lane AH, Zhu G, Nakamoto JM, Buller-Burckle AM, Wilson TA, New MI. “Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.” J Perinatol. 2013 Jan;33(1):76-8.
  632. Alan A. Parsa, Oksana Lekarev, Mabel Yau, Ahmed Khattab, Maria I. New. “Disorders of Sexual Differentiation.” In: Clinical Genomics: Practical Application in Adult Patient Care. New York: McGraw-Hill
  633. Alan A. Parsa, Oksana Lekarev, Karen Lin-Su, Mabel Yau, Ahmed Khattab, Maria I. New. “Congenital Adrenal Hyperplasia.” In: Clinical Genomics: Practical Application in Adult Patient Care. New York: McGraw-Hill
  634. Shozeb Haider, Barira Islam, Valentina D’Atri, Miriam Sgobba, Chetan Poojari, Li Sun, Tony Yuen, Mone Zaidi,Maria I. New “Structure-Phenotype Correlations of Human CYP21A2 Mutations in Congenital Adrenal Hyperplasia.” Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2605-10. doi: 10.1073/pnas.1221133110. Epub 2013 Jan 28.
  635. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, Sun L, Zaidi M, Wilson RC, Yuen T. Genotype-Phenotype Correlation in 1,507 Families with Congenital Adrenal Hyperplasia owing to 21-Hydroxylase  Deficiency. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2611-6.
  636. Tamma R, Sun L, Cuscito C, Lu P, Corcelli M, Li J, Colaianni G, Moonga SS, Di Benedetto A, Grano M, Colucci S, Yuen T, New MI, Zallone A, Zaidi M. Regulation of bone remodeling by vasopressin explains the bone loss in hypoatremia. Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18644-9. doi:10.1073/pnas.1318257110. Epub 2013 Oct 28.
  637. Khattab AM, Shackleton CH, Hughes BA, Bodalia JB, New MI. Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood. J Pediatr Endocrinol Metab. 2014 Jan 1;27(1-2):17-21.
  638. Sun L, Zhu LL, Lu P, Yuen T, Li J, Ma R, Baliram R, Moonga SS, Liu P, Zallone A, New MI, Davies TF, Zaidi M. (2013) Genetic confirmation for a central role for TNFα in the direct action of thyroid stimulating hormone on the skeleton.  Proc Natl Acad Sci USA 110:9891-6.  PMID: 23716650.
  639. Maria I. New, Yu K. Tong, Tony Yuen, Peiyong Jiang, Christian Pina, K.C. Allen Chan, Ahmed Khattab, Gary J.W. Liao, Mabel Yau, Se-Min Kim, Rossa W.K. Chiu, Li Sun, Mone Zaidi, and Y.M. Dennis Lo, “Noninvasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia Using Cell-Free Fetal DNA in Maternal Plasma.” Journal of Clinical Endocrinology and Metabolism. 99:E1022-E1030, 2014
  640. Mistry PK1, Liu J, Sun L, Chuang WL, Yuen T, Yang R, Lu P, Zhang K, Li J, Keutzer J, Stachnik A, Mennone A, Boyer JL, Jain D, Brady RO, New MI, Zaidi M.  Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.  Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4934-9.
  641. Rechman D.E., White P.C., New M.I., Rosenwaks Z, “Fertility in Patients with Congeneital Adrenal Hyperplasia.” Fertil Steril. 2014 Feb;101(2):301-9. doi: 10.1016/j.fertnstert.2013.11.002. Epub 2013 Dec 17.
  642. Katja D, Yuen T, Grubic Z, Kusec V, Barisic I, New MI. “Two Novel CYP11B1 Gene Mutations in Patients from Two Croatian Families with 11B-Hydroxylase Deficiency.” International Journal of Endocrinology. 2014 June. Vol 2014.
  643. Yau M, Khattab A, Poppas D, Ghizzoni L, New MI. “Congenital adrenal hyperplasia: unresolved issues.” Volume “Cortisol Excess and Insufficiency”, In: Frontiers of Hormone Research. Karger 2014 (in press March 2016)
  644. Khattab A, Yau M, Domenice S, Muhuri D, Costa EM, Yuen T, Pina CE, Nishi MY, Yang AC, Mendonca BB, New MI. “Pitfalls in Hormonal Diagnosis of 17B Hydroxysteroid III Dehydrogenase Deficiency.” Journal of Pediatric Endocrinology and Metabolism. 2015; 28(5-6):623-628
  645. Yau M, Pina CE, Khattab A, New M. “Congenital Adrenal Hyperplasia.” Encyclopedia of Life Sciences, John Wiley & Sons Ltd: Chichester. October 2014. DOI: 10.1002/9780470015902.a0002261.pub2
  646. Pina C, Khattab A, Katzman P, Brucker L, Andolina J, New M, Yau M. “Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy.” J Pediatr Endocrinol Metab. 2015 May; 28(5-6):663-7. DOI: 10.1515/jpem-2014-0299
  647. Di Benedetto A, Sun L, Zambonin CG, Tamma R, Nico B, Calvano CD, Colaianni G, Ji Y, Mori G, Grano M, Lu P, Colucci S, Yuen T, New MI, Zallone A, Zaidi M. “Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor.” Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16502-7. doi: 10.1073/pnas.1419349111. Epub 2014 Nov 5.
  648. Meyer-Bahlburg HFL, Reyes-Portillo JA, Khuri J, New MI. “Syndrome-Related Stigmatization by Parents, Peers, the Self as Reported by Women with Classical Congenital Adrenal Hyperplasia. Archives of Sexual Behavior.  (In Press) 2015
  649. Yuen T, Stachnik A, Iqbal J, Sgobba M, Gupta Y, Lu P, Colaianni G, Ji Y, Zhu L, Kim S, Li J, Liu P, Izadmehr S, Sangodkar J, Bailey J, Latif Y, Mujtaba S, Epstein S, Davies TF, Bian Z, Zallone A, Aggarwal AK, Haider S, New MI, Sun L, Narla G, Zaidi M. “Bisphosphonates inactivate human EGFRs to exert antitumor actions.” Proc Natl Acad Sci U S A. 2014 Dec 16; 111(50):17989-17994.
  650. Stachnik A, Yuen T, Iqbal J, Sgobba M, Gupta Y, Lu P, Colaianni G, Ji Y, Zhu LL, Kim SM, Li J, Liu P, Izadmehr S, Sangodkar J, Scherer T, Mujtaba S, Galsky M, Gomez J, Epstein S, Buettner C, Bian Z, Zallone A, Aggarwal AK, Haider S, New MI, Sun L, Narla G, Zaidi M. “Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer.” Proc Natl Acad Sci U S A. 2014 Dec 16; 111(50):17995-18000.
  651. Yau M, Pina C, Khattab A, Barhen A, New MI. “Prenatal diagnosis of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.” Expert Opinion on Orphan Drugs. 2015 May 26;3:5, 487-490.
  652. Khattab A, Yuen T, Al-Malki S, Yau M, Kazmi D, Sun L, Harbison M, Haider S, Zaidi M, New MI. “A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.” Ann N Y Acad Sci. 2015 Aug 20. Doi: 10.1111/nyas.12864. [Epub ahead of print]
  653. Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, Lu P, Sartini L, Di Comite M, Mori G, Di Benedetto A, Brunetti G, Yuen T, Sun L, Reseland JE, Colucci S, New MI, Cinti S, Grano M. “The myokine irisin increases cortical bone mass.” 2015 (In Press)
  654. Ahmed Khattab, Tony Yuen, Li Sun, Mabel Yau, Ariella Barhan, Mone Zaidi, Y. M. Dennis Lo, and Maria I New.
    Non-Invasive Prenatal Diagnosis of Congenital Adrenal Hyperplasia. Submitted to Advanced Therapies in Pediatric Endocrinology and Diabetology; In Press.

  655. Yau M, Khattab A, Nimkarn S, Lin-Su K, Almalki S, New MI. “Congenital Adrenal Hyperplasia.” In: Manual of Endocrinology and Metabolism, 5/E. Ed: Lavin. (in press)
  656. Haider S, Yuen T, Ling C, Ewert S, Mudryi V, Alzubdi M, Yau M, Khattab A, Kazmi D, Stachnik A, Toygar A,
    Ozdemir HN, Zallone A, Sun L, Zaidi M, New MI. “Structural Dynamics of Mutations in HSD111B2 Reveal Structural-Phenotype Correlations in Apparent Mineralocorticoid Excess.” Proc Natl Acad Sci U S A. 2015. In Press (pending acceptance)